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Abstract  
The bacterial SOS response is a cellular reaction to DNA damage, that, among other actions,
triggers the expression of Colicins - toxic bacteriocins in Escherichia coli that are released to
kill close relatives competing for resources. However, it is largely unkown, how the complex
network  regulating  toxin  expression  controls  the  time-point  of  toxin  release  to  prevent
premature release of inefficient protein concentrations. 
Here,  we study how different  regulatory mechanisms affect  production and release of the
bacteriocin  ColicinE2  in  Escherichia  coli.  Combining  experimental  and  theoretical
approaches,  we  demonstrate  that  the  global  carbon  storage  regulator  CsrA controls  the
duration of the delay between toxin production and release and emphasize the importance of
CsrA sequestering elements for the timing of ColicinE2 release. Here, mRNA produced from
the  ColicinE2  operon  upon  SOS  response  and  binding  to  CsrA  has  the  largest  effect.
Furthermore,  we  show  that  CsrA  additionally  binds  to  and  is  sequestrated  by  ssDNA
originating  from rolling-circle  replication  of  the  toxin-producing  plasmid.  Our  theoretical
analysis emphasizes that ssDNA is essential in ColicinE2-producing wild-type strain to enable
toxin release, by reducing the amount of free CsrA molecules in the bacterial cell.
Taken  together,  our  findings  show  that  CsrA times  ColicinE2  release  and  reveal  a  dual
function for CsrA as a ssDNA and mRNA-binding protein, introducing ssDNA as a potential
post-transcriptional gene regulatory element.
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Author Summary
Chemical warfare by bacteriocin production is one means of pathogenic bacteria to dominate
their habitat, thus increasing their potential to infect a human host. The timing of toxin release
is highly relevant, as it ensures the competitive success of its producer. Here, we show that the
time-point of ColicinE2 release is tightly regulated by the global carbon storage regulator
CsrA.  Furthermore,  we  demonstrate  that  CsrA  can  bind  to  ssDNA,  an  intermediate  of
autonomous  pColE2-P9-plasmid  replication.  Hence,  we  suggest  ssDNA as  a  new  CsrA
sequestering element, that in addition to known regulators such as the sRNAs CsrB and CsrC
or mRNAs carrying a CsrA binding site, can affect the amount of free CsrA in the bacterial
cell.
Main text 
Introduction
Many pathogenic bacteria outcompete close relatives by the secretion of toxic bacteriocins (1-
3), thereby increasing their own ability to dominate bacterial populations and thus increase
their  potential to infect a human host (3, 4). The well  studied  Escherichia coli ColicinE2
system (5-8) represents a paradigmatic model for the study of regulatory mechanisms relevant
for  toxin  production.  Here,  transcriptional  and post-transcriptional  regulation  mechanisms
control ColicinE2 expression (9). However, it is not known how this regulatory network (Fig
1a)  times  ColicinE2  production  and  release,  to  ensure  the  production  of  effective  toxin
concentrations  (cea  gene  expression)  and  to  prevent  premature  toxin  release  (cel  gene
expression) in the wild-type strain CWT.
Bacteriocins, including ColicinE2, are plasmid encoded and heterogeneously expressed (10-
13) from operons  under  the  control  of  an  SOS promoter  (9,  14) in  response  to  external
stresses. The ColicinE2 operon consists of three genes: cea (the colicin activity gene), cei (the
immunity gene) and cel (the lysis gene) (Fig 1a). Upon induction of the SOS response, RecA
induces  autocleavage of  LexA dimers,  which permits the production of two mRNAs: the
‘short’ transcript including cea and cei, and the ‘long’ one comprising all three genes (9). Co-
expression of the genes cea and cei is necessary, since the immunity protein ensures that the
colicin remains inactive for as long as the colicin-immunity protein complex is present within
the cell. This complex (15) is secreted upon cel gene expression (16), which leads to the death
of  the  bacterial  cell,  secreting  the  colicin.  Translation  of  the  cel  gene  is  regulated  post-
transcriptionally by the mRNA binding protein CsrA (17, 18).  The abundance of CsrA is
further regulated by the two CsrA binding sRNAs CsrB and CsrC (19). 
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Results 
To study how the ColicinE2 regulatory network controls the timing of toxin expression, we
investigated the dynamics of toxin production and release using a combined experimental and
theoretical approach. In order to clearly distinguish toxin-expressing cells from cells that did
not produce and release the toxin or only at basal levels, we introduced an additional multi-
copy reporter plasmid (pMO3,  Methods) into the wild-type strain CWT, in which the genes
cea and  cel are replaced by sequences encoding Yellow and Cerulean fluorescence proteins
(YFP and CFP), respectively (Methods), resulting in the reporter strain CREP1. This double
reporter  plasmid  carries  all  genetic  sequences  relevant  for  transcriptional  and  post-
transcriptional regulation found in the original ColicinE2 operon (Fig 1a,b). This ensures that
the expression of the YFP and CFP directly reflects the normal expression patterns of the cea
(toxin production) and cel (toxin release) genes (13). Using single-cell time-lapse microscopy
(Methods,  Fig  S1)  (13),  we  found  that  CREP1 expresses  the  cea  and  cel  genes  nearly
simultaneously (Fig 1c-d), with an insignificant delay of 4 ± 2 min. 
This observation, however, is biologically implausible, as it would prevent the accumulation
of effective toxin concentrations. In addition, theoretical investigations (20) of the ColicinE2
network predicted a significant delay between cea and cel gene expression. These conflicting
results  thus  suggested  that  the  introduction  of  the  multi-copy  reporter  plasmid  somehow
affected the cea-cel delay, potentially by interfering with regulatory mechanisms derived from
or otherwise linked to the ColicinE2-P9 plasmid of the wild-type strain CWT, controlling the
timing of cea and cel expression. 
To address this question, we created a second reporter strain, SREP1, which only carries the
double reporter plasmid, but lacks the original pColE2-P9 plasmid (Table S2, Fig S1). In this
strain, we find a significant delay of 75 ± 6 min between cea and cel gene expression, with a
slight decrease in delay times at higher stress levels, imposed by increasing the level of the
SOS response-inducing agent Mitomycin C (MitC) in the medium (Fig 1c,d). This indicated
that the original pColE2-P9 plasmid in the CREP1 strain, which the SREP1 strain lacks, contains
additional regulatory elements that are responsible for the reduction of the cea-cel delay in the
CREP1 strain. 
To disentangle the roles of the various regulatory elements controlling the cea-cel delay, we
first  analysed the roles  of known transcriptional  and post-transcriptional  regulators  of the
ColicinE2 network. In the second step, we studied further regulatory elements present on the
original  ColicinE2-P9  plasmid.  Finally,  we  integrated  the  observations  made  in  these
experiments into a theoretical model, to uncover the major regulatory elements controlling the
cea-cel delay in CWT.
In the first step, we asked whether and how the cea-cel delay observed in the SREP1 strain is
affected by individual regulatory modules (transcriptional and post-transcriptional), starting
with the role of the transcriptional repressor LexA.  To assess the impact of transcriptional
regulation by LexA on the duration of the delay between  cea and  cel  gene expression, we
created two SREP1 strain mutants in which the LexA binding sites on the reporter plasmid had
been altered, such that LexA binding was expected to increase (LexA1) or decrease (LexA2)
(Methods).  As  expected,  the  maximal  fluorescence  intensity  (FImax)  and  the  fraction  of
ColicinE2 expressing cells (% ON) were decreased in the LexA1 mutant (Fig S2), while the
delay time did not differ significantly from that of the SREP1 strain, indicating that stronger
LexA binding does not affect the delay between cea and cel gene expression.
In contrast to our expectations, however, the values for FImax and % ON were also lower in the
LexA2 mutant. Moreover, the cea-cel delay was also markedly affected, falling to 36 ± 6 min
in comparison to 75 ± 6 min for the SREP1 strain (Fig S2). This decrease is accounted for by the
shift in the tON distribution for cea expression to later time-points (the time-point tON marks the
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onset of the 'ON' state,  Methods,  Fig S2), indicating the absence of a post-transcriptional
regulation effect. Kamensek  et al.(21) report that an additional protein, AsnC, controls the
temporal induction of the ColicinE2 operon in concert with LexA. As the AsnC protein also
binds within the LexA binding sites (21, 22), changes in the LexA binding site could also alter
AsnC binding, thus affecting the initiation of ColicinE2 transcription. Hence, we conclude
that the delay between cea and cel gene expression can be shortened by altering the timing of
the onset of  cea expression (tONcea), but that it is difficult to determine which transcriptional
protein (LexA or AsnC) is causing the shift in tONcea. However, the observed reduction of the
cea-cel delay in the LexA2 mutant was insufficient to explain the simultaneous expression of
cea and cel genes in the CREP1 strain.
A second regulatory element essential for ColicinE2 expression is the global carbon storage
regulator  CsrA,  which  inhibits  cel expression  by  binding  to  the  Shine-Dalgarno  (S-D)
sequence  present  in  the  long  mRNA (Fig  1a).  To investigate  the  influence  of  the  post-
transcriptional regulator CsrA on the ColicinE2 expression dynamics, we created two SREP1
strain mutants with altered CsrA binding sites on the pMO3 reporter plasmid (Methods), such
that CsrA binding to the S-D sequence was either increased (CsrA1) or reduced (CsrA2) (Fig
2).  As expected,  cea expression was unaffected in both mutants (Fig 2a-c).  In the CsrA1
mutant, the fraction of cells expressing the cel  gene (% ON), and the maximal fluorescence
intensity (FImax) of the cells in the ON state, was reduced. In contrast, FImax and % ON were
increased in the CsrA2 mutant (Fig 2a,b). While the CsrA1 mutant showed an increased mean
cea-cel delay with 94 ± 6 min, the CsrA2 mutant displayed a markedly shorter delay of 12 ± 2
min in comparison to the SREP1 strain (Fig 2e). This shortening of the cea-cel delay is due to
the earlier onset of cel gene expression (tONcel), while the timing of cea gene expression (tONcea)
is nearly unaffected (Fig 2c). 
To elucidate the role of CsrA theoretically, we extended our previous mathematical model
(20). This generalized model emulates the complex dynamical behaviour of the regulatory
components and accounts for all regulatory interactions discussed here, including the different
plasmid compositions and abundances that characterize the three strains CREP1, SREP1 and CWT
(Fig S3, Table S5, please see SI for details of the theoretical model). As the model enables us
to  study  various  parameter  values  of  these  interactions,  it  gives  us  a  controlled  way  to
investigate  the  influence  of  the  different  regulatory  components  and  mechanisms  on  the
production and release of ColicinE2. To show that our model is indeed valid, we employed
parameters  motivated  by experimental  studies  (see  SI for  details)  to  reproduce  the  delay
distribution of the SREP1 strain (Figs. 2e, 2f). In agreement with the above experiment, we also
find that alteration of kM, which quantifies binding of CsrA to long mRNA resulted either in an
increase (kM = 0,0125) or a decrease (kM = 0.0018) of the mean cea-cel delay in the SREP1 strain
(Fig 2f). Hence, our combined experimental and theoretical analysis demonstrates that CsrA
mediates the delay between toxin production and release.
While CsrA directly affects the  cea-cel delay by deferring  cel gene expression, regulatory
elements that sequester CsrA can indirectly affect the duration of the delay by controlling the
abundance of the free CsrA protein. Two known CsrA-sequestering elements are the sRNAs
CsrB and CsrC (23-25). Hence, deletion of these sRNAs should lead to a strong increase in
CsrA abundance and consequently extend the cea-cel delay. To investigate the role of these
sRNAs in ColicinE2 expression, we first created a knock-out SREP1 strain mutant (Methods)
lacking the sRNA CsrB, which includes 18  imperfect repeat sequences that serve as CsrA
binding  sites  (in  comparison  to  only  9  in  CsrC)(24).  We find  that  neither  cea nor  cel
expression is significantly altered in the mutant (Fig S2). This finding was confirmed in long-
term experiments, where a decrease in FImax  was observed only in the very late stationary
phase (Methods, Fig S4) - which can be explained by a compensatory effect of the second
sRNA CsrC(24). Accordingly, the delay was only slightly decreased (to 68  ± 6 min)  in the
CsrB mutant (Fig S2). In contrast to our expectations, a double sRNA knock-out in the SREP1
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strain (deletion of both CsrB and CsrC) showed increased FImax (Figs S2 and S4) and slightly
altered % ON values for both  cea and  cel  gene expression (Fig S2). Interestingly, also the
delay between cea and cel gene expression was significantly reduced (to 36 ± 5 min) relative
to the SREP1 strain (Fig S2). In addition, the onset of expression, tON, was shifted to earlier time-
points for both  cea and  cel (Fig S2),  indicating that  transcription of the entire  ColicinE2
operon was prematurely induced,  due to  the increased availability  of  CsrA.  A connection
between  CsrA  abundance  and  the  LexA-RecA  network  was  previously  described  for
ColicinE7  expression(26).  The  reduction  of  the  cea-cel delay  was  primarily  due  to  the
pronounced shift of tONcel to earlier time points in comparison to the small shift in tONcea. Hence,
our data imply that while deletion of a single sRNA does not affect ColicinE2 expression
significantly (Figs S2 and S4), deletion of both sRNAs (CsrB and CsrC) leads to premature
production and release of ColicinE2 (Fig S2). This result points to the intervention of yet
unknown regulatory mechanisms.Up to now, we have considered the impact on ColicinE2
expression of regulatory factors that are present in both SREP1 and CREP1 strains. However, it
was still unclear which regulatory element deriving from the original pColicinE2-P9 plasmid
(Fig S5) reduces the cea-cel delay in the CREP1 strain. The observed differences in the cea-cel
delay in the CREP1 versus SREP1 strain could be due to the additional 20 pColE2-P9 plasmids in
the CREP1 strain, increasing the plasmid copy number in this strain to 75 compared to 55 in the
SREP1 strain (SI). As the plasmid copy number correlates with the amount of long mRNA in the
presence of an SOS response, consequently, a higher amount of long mRNA able to sequester
CsrA is present in CREP1. To estimate the effect of the plasmid copy number/amount of long
mRNA on the cea-cel delay, we accounted for the exact plasmid composition for each strain
in  the  theoretical  modelling  (SI).  As  described  above,  for  the  SREP1 strain  the  theoretical
analysis accurately retrieved the experimentally observed cea-cel delay of 67 min (Fig. 2e,f
and Fig S6). For CREP1 the theoretical model predicted a delay of about 24 min (Fig S6) that
was significantly longer than the experimentally observed delay of 4 min (Fig. 1d). To further
study the impact of the plasmid copy number on the cea-cel delay, we changed the origin of
replication of the reporter plasmid in the way, that now only ~ 13 reporter plasmids per cell
are produced, resulting in strains CREP2 and SREP2  (Methods, Table S2). A reduction of the
plasmid copy number should extend the cea-cel delay, as now less long mRNA is produced
and consequently more free CsrA molecules are able to bind at the S-D sequence of the cel
gene. Indeed, the XREP2 strains with a decreased amount in total plasmid copy number show
increased  delay  times  compared  to  their  corresponding  XREP1 strain.  For  CREP2  with  ~  33
plasmid copies in total (Methods) we obtain a cea-cel delay of 25 ±  4 min. For SREP2 with ~13
plasmid copies we find a delay of > 101 min, as here 67% of the cells do not express the cel
gene and consequently do not lyse during the time frame of the experiment.   Hence,  the
higher amount of long mRNA due to an increased plasmid copy number explains a strong
reduction in the  cea-cel delay. However, it  cannot  explain the discrepancy in delay times
between the C and S strains, with the C strains having delay times much shorter as expected
with regard to their plasmid copy number.
Consequently,  we investigated genetic elements on or deriving from the pColE2-P9 plasmid
that  might  affect  ColicinE2  expression.  We  sequenced  the  entire  pColE2-P9  plasmid
(Methods,  Fig  S5a,  Genbank  accession  number  KY348421)  and  performed  a  homology
comparison of genes present on this plasmid with part of the closely related plasmid pColE3-
CA38  (Table  S1).  As  in  pColE3-CA38,  most  genes  on  pColE2-P9  are  involved  in
autonomous plasmid replication (SI), but we could not find a link between these genes and
regulatory elements affecting ColicinE2 expression. At this point, we recalled that rolling-
circle replication (SI) can lead to the accumulation of a ssDNA intermediate, as was shown
for pColE3-CA38 (27). This ssDNA could interact with other regulatory elements affecting
ColicinE2  expression,  e.g.  sequester  the  global  regulatory  protein  CsrA,  thereby  further
reducing the cea-cel delay in the CREP strains. To address this hypothesis, we first confirmed
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the accumulation of ssDNA for cells carrying the pColE2-P9 plasmid (Fig 3) in the absence
and presence of the SOS inducing agent MitC (Fig S5b). Secondly, we performed gel shift
analysis to investigate the binding of CsrA to both long mRNA and ssDNA (Methods,  SI).
We find that CsrA binds to a RNA oligo carrying the original nucleotide sequence of the long
mRNA with a Kd of  22  ± 13 nM, which is  in good accordance with values described in
literature (17, 28). Furthermore, we found that the mRNA binding protein CsrA is able to bind
to ssDNA with a Kd of  991 ±164  nM (Methods, Fig S5c,d). The binding strength of CsrA to
ssDNA is therefore by a factor of 45 lower as the binding strength of CsrA to sRNA (Fig. 2d).
This  finding,  that  CsrA can  bind  both  sRNA as  well  as  ssDNA was  in  accordance  with
previous studies revealing that CsrA possesses a KH domain (29),  a domain that is known to
enable proteins to bind to mRNA as well as ssDNA (30, 31).  To investigate if CsrA binds
ssDNA at the known CsrA binding sites (Table S4) for CsrA-RNA interaction (17, 32), we
studied the binding of CsrA to ssDNA with altered CsrA binding sites. We introduced the
same changes in the CsrA binding site as done before for the RNA (Fig. 2d, Table S4). As
seen for CsrA binding to RNA, we find that CsrA binds stronger to the sequence that should
allow for stronger CsrA binding (Methods, CsrA1 sequence), and that CsrA binds weaker to
the  sequence  that  should  weaken CsrA binding due  to  impaired  formation  of  the  second
hairpin harbouring the second CsrA binding site (Fig S5d, Methods, CsrA2 sequence). This
indicates that CsrA uses the same binding motives on the ssDNA as on the RNA - namely the
GGA motive, with the neighbouring bases enabling the establishment of a hairpin structure
exposing the GGA motive to allow for accurate CsrA binding(32). However, binding of CsrA
to ssDNA is by a factor of 45 less efficient than binding of CsrA to RNA. Still, ssDNA can
serve as an additional CsrA sequestering element, as ssDNA is produced continuously during
the bacterial cell cycle and accumulates in the cell to very high numbers (Fig. 3, Fig S5b). In
contrast,  long  mRNA  sequestering  CsrA  is  produced  only  upon  induction  of  the  SOS
response.
To support  our  hypothesis  that  ssDNA as  an  additional  CsrA sequestering  element  could
further reduce the cea-cel delay in the CREP strains but also in the CWT strain, we incorporated
this additional regulatory element into the theoretical model (SI, Figs S6 and S7). We find
that the presence of ssDNA additionally reduces CsrA abundance in the CREP and CWT strains.
Furthermore, the presence of ssDNA in combination with the high amount of long mRNA
totally suppresses the  cea-cel delay due to the increased plasmid copy number in the CREP1
strain by CsrA sequestration (Fig 4). For the natural CWT strain carrying only the 20 pColE2-
P9  plasmids,  our  model  predicts  that  the  cea-cel delay  lasts  approximately  one  hour.
Furthermore, the cea-cel delay is broadly distributed in the wild-type strain CWT. Importantly,
cel gene expression and consequently toxin release in the CWT strain only occurs within the
time-frame of our experimental studies if ssDNA is present (Fig 4, Fig S8). Hence, the delay
time of a particular strain that is determined by the abundance of free CsrA is controlled by
three CrsA sequestering components (Fig. 5a). First, the action of the sRNAs that are present
in all strains studied in this work. Second, the amount of long mRNA that depends on the type
and number of plasmid present in the particular strain (Fig. 5b, SI, Table S5) and third, the
additional accumulation of ssDNA in strains carrying the pColE2-P9 plasmid (C strains, Fig.
5b).  Notably,  the  effect  of  these  three  CsrA sequestering  elements  differs  due  to  their
occurrence  (SI);  e.g.  while  long  mRNA is  only  produced  upon  induction  via  the  SOS
response, ssDNA is produced independently due to  autonomous rolling circle replication in
the presence and absence of an SOS response (Fig S5b).
Discussion
In this study, we investigated regulatory factors controlling ColicinE2 production and release
in response to an SOS signal and demonstrate that the global carbon storage regulator CsrA
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controls the time-point of ColicinE2 release in Escherichia coli.  The mRNA binding protein
CsrA is  highly  abundant  in  the  E.  coli  cell,  with  11.000-33.000 CsrA molecules  in  total
(bound and unbound) (18). However, Taniguchi et al., report that only a small fraction of 474
CrsA molecules  per  cell  are  freely  available  (33).  This  indicates  that  CsrA sequestering
elements can strongly affect the amount of free CsrA in the bacterial cell. 
Two well studied CsrA sequestering components are the sRNAs CsrB and CsrC (18, 24, 25).
It was shown that CsrB alone can bind up to 32% of CsrA present in the bacterial cell (18). In
this study, we were able to show that besides these sRNAs, also mRNAs that carry a CsrA
binding site (34) can strongly reduce the abundance of free CsrA. Furthermore, we verified
that CsrA is able to bind to ssDNA originating from autonomously replicating plasmids. Our
data indicate that CsrA is thereby binding to the GGA motive exposed in the second hairpin
loop present in both ssDNA and long mRNA deriving from the pColE2-P9. This demonstrates
the dual role of CsrA as an mRNA and ssDNA binding protein. In addition, our study shows
that in  E. coli cells  carrying autonomously replicating plasmids with a CsrA binding site,
ssDNA deriving from these plasmids can serve as an additional CsrA sequestering element.
We speculate that ssDNA accumulating in bacterial cells could play an important regulatory
role  in  other  protein-expressing  networks  that  rely  on  the  expression  of  proteins  from
autonomously replicating plasmids, as is the case for many bacteriocin-producing networks. 
With  regard  to  the  ColicinE2  system,  our  combined  experimental  and  theoretical  efforts
allowed us to disentangle the different regulatory mechanisms affecting the delay between
toxin  production  and  release.  We revealed  that  the  interplay  between  CsrA and  ssDNA,
sRNAs and long mRNA, times toxin release upon induction of the SOS response (Fig 5). In
particular, our theoretical investigations emphasized that the presence of ssDNA can enable
the toxin producer to release the toxin within few hours once an SOS response has been
triggered. From an evolutionary perspective, a short delay might be important for the toxin
producing colony to respond quickly to changing environmental conditions and to increase its
competitive success.
Material and Methods 
Creation of bacterial strains used in this study
All strains used in this study are listed in SI (Table S2). The strain CWT represents the original
wild-type strain, which carries the toxin-producing plasmid pColE2-P9. The CREP1 strain and
the SREP1 strain (EMO3-C and EMO3-S, respectively) were constructed as described in Mader
et al (13). Both strains carry the double reporter plasmid pMO3 (13). This plasmid, pMO3,
harbours the entire ColicinE2 operon, in which the genes cea and cel have been replaced by
genes  coding  for  the  fluorescence  proteins  (FP)  mVenus  (YFP)  and  mCerulean  (CFP),
respectively (Fig 1).  Hence,  this  plasmid retains  all  regulatory sequences relevant  for  the
binding of LexA to the SOS box of the ColicinE2 operon, and of CsrA to the Shine-Dalgarno
sequence on the resulting long mRNA. To investigate the role of specific regulatory elements
on the duration of the delay between cea  and cel expression, all mutant strains used in this
study are  derived from EMO3-S,  the  SREP1 strain.  Construction  of  these mutant  strains  is
described in the following.
To investigate the impact of the transcriptional repressor LexA on Colicin E2 expression, we
altered the LexA binding site on the pMO3 reporter plasmid using site-directed mutagenesis
with  the  Quick  ChangeII  kit  (Agilent  Technologies).  According  to  Lewis  et  al.  (30),  the
strength of LexA binding to the two overlapping SOS boxes (LexA binding sites) can be
estimated from the HI index. Based on these estimations, we created two LexA mutants (SI):
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LexA1 was created using primer pair P1/P2 (SI). The base exchange AT-to-TA on pMO3 (SI)
is expected to lead to tighter LexA binding, with a HI factor of 8.6 for the first SOS box,
which is the more important for LexA binding (35). The resulting plasmid was named pMO4
(SI). LexA2 was created using the primer pair P3/P4 (SI). The base exchange of CTG-to-
CCC in the first SOS box on pMO3 (SI) is expected to weaken LexA binding, with a HI index
of 21.13 for the mutant sequence. The resulting plasmid was named pMO5 (SI).
To analyze the post-transcriptional impact of the mRNA-binding protein CsrA on ColicinE2
expression,  we  altered  the  CsrA binding  site  on  the  pMO3  reporter  using  site-directed
mutagenesis as described above. In the first mutant strain (CsrA1), we introduced a mutation
(GTC to TGT) in the second CsrA binding site  (SI) within the Shine-Dalgarno sequence of
the  cel/cfp gene on pMO3 using the primers P5 and P6 (SI), generating the plasmid pMO6
(SI). This mutation optimizes the CsrA binding site (32) and therefore increases CsrA binding
to  pMO6 relative  to  pMO3 (Fig  2a).  In  the  second  mutant  (CsrA2),  CsrA binding  was
decreased (32, 36) (Fig 2a) by using the primer pair P7/P8 (SI) to alter AC to TT in the
second CsrA binding site in the Shine-Dalgarno sequence of the cel/cfp gene on pMO3, thus
inhibiting  formation of the second mRNA hairpin. The resulting plasmid was named pMO7
(SI). 
To understand the roles of the sRNAs CsrB and CsrC in CsrA sequestration and consequently
in ColicinE2 expression, single and double knock-out mutants for these sRNAs were created
using the Quick&Easy E.coli Gene Deletion Kit Nr.6 (Gene Bridges, Heidelberg, Germany).
The gene coding for the sRNA CsrB was replaced in strain BZB 1011 with a kanamycin
resistance cassette using the primer pair P9/P10  (SI). The resulting strain was named BZB
1011::CsrB,  and  the  reporter  plasmid  pMO3 was  transformed  into  this  strain  to  produce
EMO3::CsrB (CsrB) (SI).  The single knock-out mutant  of  CsrC was created in  a similar
manner (primer P11/P12, SI), and was also used for the double sRNA knock-out. Here, the
genomic region coding for the sRNA CsrC was replaced by a kanamycin resistance cassette.
In  next  step,  the  primers  P9  and  P10  (SI) were  used  to  replace  the  CsrB  gene  with  a
chloramphenicol resistance cassette. This strain was named BZB 1011::CsrB/C, and it too was
transformed with the plasmid pMO3 to generate EMO3::CsrB/C (CsrB/C) (SI).  
Creation of CREP2 and SREP2
The reporter plasmid of the XREP2 strains was created by a PCR of the plasmid pMO3 with the
primer P25 and P26, which delete the ORI of the pMO3 plasmid. The new ORI p15A was
replicated via PCR using primer P27 and P28 from the Vector pZA11MCS (EXPRESSYS).
After gel purification of the vector using the Freeze 'N Squeeze™ DNA Gel Extraction Spin
Columns (bio-rad), both, the vector and the ORI p15A were cut with the enzymes SalI-HF and
SphI-HF (NEB) and ligated in a 1:5 ratio of vector:insert using an ElectroLigase® (NEB).
The resulting plasmid pMO8 was transformed into an E.coli strain (XL1) for replication using
an MicroPilaser Electroporation Apparatus (bio-rad) and selected on ampicillin plates. After
purification of the pMO8 plasmid using a QIAprep Spin Miniprep Kit (Qiagen), the reporter
strains SREP2 and CREP2 were created via transformation of pMO8 into BZB 1011 and CWT,
respectively, with the bio-rad electroporator. 
To verify the copy number of the pMO3 and pMO8 plasmids in the SREP1 and SREP2 strains,
respectively, the bacteria were grown in M63 medium with antibiotic over night at 37°C and
300rpm. The cultures were then diluted to OD600 in an equal volume and the plasmids were
purified using the QIAprep Spin Miniprep Kit (Qiagen). The concentration of the DNA was
measured using the NANODROP 1000 instrument (ThermoScientific). This lead to a copy
number of 55 ± 11 and 13 ± 4 plasmids per cell for the SREP1 and SREP2 strain, respectively.
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Fluorescence microscopy 
Bacteria were grown overnight at 37°C in M63 minimal medium supplemented with 0.5%
glycerol as a carbon source, and with 100 µg/ml ampicillin (Carl Roth, Germany) if required.
Overnight cultures were diluted to an OD600 of 0.05 and grown to an OD600 of 0.2, which
represents the beginning of the exponential growth phase. Aliquots (50 µl) of these cultures
were  allowed to  attach  to  poly-L-lysine  (BIOCHROM, Berlin)-coated  Ibidi  µ-slides  VI0.4
(Ibidi GmbH, Munich) for 7.5 min and rinsed to remove unattached bacteria(13). For time-
lapse experiments,  slides  were then  transferred to  an inverse  microscope,  Axiovert  200M
(Carl  Zeiss,  Germany)  equipped  with  an  Andor  camera  and  a  Zeiss  EC  Plan-Neofluar
100x/1.3  oil-immersion  objective.  A filter  set  with  a  beam splitter  BS520,  an  excitation
bandpass HC500/24 and an emission bandpass HC 542/27 was used for YFP detection. The
HC filter set for CFP detection consisted of an emission filter 483/32, a beam splitter BS458
and an excitation filter 438/24. To minimize fluorescence variations deriving from day-to-day
fluctuations of the excitation source,  the stability  of the absolute fluorescence values was
verified daily using a microscope image intensity calibration kit (Invitrogen, FokalCheck™
fluorescence  microscope  test  slide  #3)  and  data  sets  were  corrected  accordingly.
Micromanager, an open-source program (version 1.3), was used for image acquisition (37).
After  the  first  image,  the  chamber  was  flushed  with  medium containing  the  appropriate
concentration  of  mitomycin  C (MitC,  Carl  Roth,  Germany).  Subsequently, an image was
taken every 15 min over a period of 300 min. Images were analyzed using the Cell Evaluator
plug-in (38) for ImageJ. Only live cells lying within the bright-field image were considered.
General data analysis was performed using IgorPRO 6.22, Matlab (R2013b) and Adobe CS5
Software.  FImax  represents  the  average  maximal  fluorescence  intensity  of  single  cells
expressing the Colicin E2 operon. To quantify the numbers of cells expressing the FPs YFP
and CFP (cea and cel gene expression, respectively) a threshold level was set to distinguish
expressors  from non-expressors,  as  described  earlier  (13).  The  resulting  fraction  of  cells
expressing either  cea  or  cel is given as the cumulative fraction. The time-point tON which
marks the onset of the 'ON' state is defined as the time at which fluorescence exceeds this
switching threshold. The delay time between cea and cel gene expression was then calculated
as the mean of the tONcel - tONcea values for individual cells expressing both cea and cel. Upon
induction with MitC, the parameters FImax, % ON (Fig S1) and delay time (Fig 1c) show only
little  variation  with  MitC  concentration  (0.1,  0.25  and  0.4  µg/ml).  Consequently,  data
presented  in  Fig  2,  and  Fig  S2 represent  the  average  values  of  these  three  MitC
concentrations to allow for better comparability and to improve statistics. 
Long-term analysis of fluorescence development
To investigate the role of sRNA knock-outs on cea and cel gene expression on a longer time-
scale, experiments were performed with the Fluostar Optima Plate Reader (BMG Labtech).  A
500-µl  aliquot  of  a  starter  culture  at  OD600 0.2  was  induced  with  the  appropriate  MitC
concentration as described above. To prevent cultures from drying out, the plate was sealed
with an O2 permeable foil. Antibiotics were added as required, ampicillin at 100 µg/ml (Carl
Roth,  Germany),  kanamycin at  50 µg/ml (Carl  Roth,  Germany) and chloramphenicol at  5
µg/ml (Carl Roth, Germany). Bacterial growth (absorbance) and YFP and CFP fluorescence
development (representing cea and cel expression, respectively) was followed over a period
of 16 h at 37°C, with shaking at 300 rpm. 
ssDNA accumulation and purification
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Bacterial strains were grown overnight at 37°C in shaken cultures. The overnight cultures
were induced for approximately 75 min with 0.25 µg/ml MitC. Plasmid/ssDNA extraction
was performed using the Miniprep Kit (Qiagen, Germany), and 1 µg each of CWT  and SREP1
strain extracts was cleaved with PvuI (New England Biolabs (NEB), Germany). Then 300 ng
of  both  cut  and uncut  CWT and  SREP1 strain  extracts  were  applied  to  an  1% agarose  gel,
prestained with EtBr. To validate the presence of ssDNA, single-stranded circular Phi174 and
M13mp18 viral DNAs (NEB, Germany) were also applied to the gel (Fig 3).
Sequencing and homology analysis
Sequencing  of  the  6757-bp  pColE2-P9  was  performed  by  MWG  Eurofins  Genomics
(Germany) using an ABI 3730XL sequencing instrument and the sequencing primers (P13-
P24)  listed in the  SI. The sequences of specific segments such as the 2640-bp ColicinE2
operon (Genbank M29885) and the Rep protein region (Genbank D30054) were verified. In
all,  1754 bp were  sequenced  de  novo,  and  the  resulting  plasmid  map  of  the  completely
sequenced  pColicinE2-P9  is  given  in  Fig  S5a.  The  pColicinE2-P9  sequence  has  been
deposited in GenBank (accession number  KY348421). We also used the NCBI online tool
BLAST to compare the sequences of genes in the pColE2-P9 plasmid with their homologues
in pColE3-CA38, for which ssDNA accumulation was shown previously (27). The sequence
homologies are given in Table S1.
Gel shift analysis
To determine the affinities of CsrA for three different RNA constructs representing the CsrA
binding sites present in pMO3, pMO6 und pMO7 (SI, Table S4)  we performed gel  shift
analysis.  The N-terminal  6xHis-tagged CsrA protein used for  gel  shift  measurements  was
obtained from Biozol (Germany). The folding structures of the oligos, were analyzed using
the Mfold web server (39), and showed the expected double-hairpin structure that facilitates
CsrA binding in the RNAs derived from pMO3, pMO6 and the ssDNA. The RNA of pMO7
however lacks this structure. The RNA was folded for 3.5 min at 85°C in 10 mM Tris-HCl, 1
mM EDTA, 200 mM KCl, 20 mM MgCl2 buffer. ssDNA folding was performed under the
same conditions but with 90°C. 
For the gel shift analysis of RNA binding to CsrA (Fig S5c), serial 2-fold dilutions were made
from a  6600 nM stock solution of CsrA (down to approximately 0.8nM CsrA). 
To verify binding of CsrA to ssDNA we performed the same gel shift analysis as done for the
sRNA oligos, with sequences of 89-bp ssDNA oligos equivalent to pMO3, pMO6 and pMO7
(SI, Table S4). The samples for ssDNA gel shift analysis were prepared by doing a serial
dilution  starting  with  33.3µM  CsrA stock  solution  (to  a  minimal  CsrA concentration  of
approx. 4nM CsrA). 
The binding reaction was performed  in a buffer containing 15 mM Tris-HCl, 0.5 mM EDTA,
250  mM  NaCl,  50mM  KCl,  5  mM  MgCl2,  3.25  ng/µl  yeast  RNA,  4U  RNase  inhibitor
(Ambion) and 10% glycerol buffer and incubated at 37°C for 30min.
Gel  shift  measurements  were  performed  at  room temperature  with  precast  4–20% Mini-
PROTEAN® TGX™ Precast Protein Gels (bio-rad) in Tris/Glycine Buffer (bio-rad) and run
at 85V for 1h. Pictures of the gel shift were taken with the gel chamber ChemiDocTM  MP
Imaging System (bio-rad) using filters for Cy5 labels. 
Using the ImageJ software the intensity decrease in the unbound band of RNA and ssDNA for
increasing CsrA concentrations was analysed for all gel shifts and plotted with IgorPro 7.04.
The curves were then fitted using the following equation that was adapted from (40).
()[ √( )❑❑ ]
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Here FI is the measured fluorescence intensity of the RNA/ssDNA unbound band, m is the
maximum  FI,  b  the  basal  FI,  R  the  used  RNA/ssDNA  concentration  and  P  the  CsrA
concentration. The Kd for CsrA binding to ssDNA and RNA was determined on three separate
days.  
Theoretical modelling
For the theoretical analysis performed in this study we refer the reader to the SI.
Supplementary Information (SI): SI appendix (description of theoretical investigations and
further experimental results and methods, eight supplementary figures and five supplementary
tables) have been provided to support this article.
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Figure captions
Fig 1: Time between toxin production and release. A) The regulatory network controlling
the delay between ColicinE2 production (cea) and release (cel) in CWT. The operon expresses
the genes cea (ColicinE2), cei (immunity protein) and cel (protein inducing cell lysis). In the
reporter  plasmid,  the  genes  cea and  cel are  replaced  by  genes  encoding  the  fluorescent
proteins YFP and CFP, respectively. The transcriptional repressor LexA inhibits expression of
the operon. Cell stress causes RecA-mediated auto-cleavage of LexA dimers. Subsequently, a
short  cea-cei and  a  long  cea-cei-cel mRNA are  produced.  Expression  of  cel is  further
regulated  post-transcriptionally  by binding of  CsrA to  the  Shine-Dalgarno sequence  (SD)
within the T1 transcriptional terminator. CsrA itself is regulated by two sRNAs, CsrB and
CsrC. B) Plasmids present in the two reporter strains CREP1 and SREP1. The CREP1 strain carries
both the reporter plasmid pMO3 and pColE2-P9. The SREP1 strain carries only the reporter
plasmid.  C) Dependence of the delay between ColicinE2 production and release by CREP1
(black) and SREP1 (grey) on the level of external stress (MitC concentration). D) Average delay
between ColicinE2 production and release by CREP1 (black) and SREP1 strains (grey). Error bars
depict the standard error of the mean (SEM).
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Fig 2: CsrA regulates the delay between ColicinE2 production (cea) and release (cel). A-
C)  Yellow: cea gene expression, blue cel gene expression of cells expressing the ColicinE2
operon in the SREP1 strain in comparison to mutant strains CsrA1 and CsrA2. Error bars depict
the standard error of the mean (SEM).  A) Maximal fluorescence intensity,  B) Cumulative
fraction  of  cells  expressing  the  ColicinE2  operon,  C) TON times  for  cea and  cel gene
expression. D) Dissociation constants (Kd) for the binding of CsrA to various RNA oligos
(SI).  E) Experimentally observed  cea-cel delay.  F) Theoretically determined mean  cea-cel
delay. CREP1 (kM = 0,007), SREP1 (kM = 0. 0,007), CsrA1 (kM = 0,0125), CsrA2 (kM = 0.0018).
kM is the theoretical binding rate constant for CsrA binding to the long mRNA.
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Figure 3: Accumulation of ssDNA in CWT. Agarose gel of plasmid and ssDNAs extracted
from CWT and SREP1 strains. Lanes 1-4 and 9-12 were loaded with the indicated markers: 1-kb
ladder,  super-coiled  ladder;  7249-bp  ssDNA ring  (M13mp18),  and  5386-bp  ssDNA ring
(PhiX174). Lane 5: uncleaved CWT DNA showing the 6800-bp pColE2-P9 dsDNA (blue) and
ssDNA (red). Lane 6: CWT DNA cleaved with PvuI, showing the linearized ds pColE2-P9
plasmid (yellow). Lane 7: uncleaved SREP1 strain DNA showing the 5600-bp reporter plasmid
(blue).  Lane 8:  SREP1 strain  DNA cut  with  PvuI,  showing the  linearized  reporter  plasmid
(yellow).
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Figure 4: Theoretical analysis emphasizes the importance of the sequestering of CsrA by
ssDNA for toxin release in CWT. A) Plasmids and ssDNA (grey loops) present in the  SREPx,
CREPx and CWT strains. B,C) Theoretical analysis of the cea-cel delay for all strains emphasizes
the importance of ssDNA for the timing of toxin release in the colicin-producing strains (CREPx
and CWT). B: no ssDNA present. C: ssDNA present with D = 7. The orange line indicates the
mean  experimental  delay  for  the  corresponding  strain,  the  blue  line  the  corresponding
theoretical value. The red bar on the right depicts the fraction of cells not undergoing cell lysis
in the theoretical model..
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Fig.  5:  Time-point  of  ColicinE2  release  is  regulated  by  the  global  carbon  storage
regulator CsrA. A)  CsrA controls  the  delay  between  toxin  production  and release.  This
mechanism prevents premature release of ineffective toxin concentrations. CsrA abundance is
regulated by several components: the long mRNA transcribed from the pColE2-P9 plasmid
and  the  reporter  plasmid  pMO3 (or  pMO8),  the  sRNAs  CsrB and  CsrC,  and  the  newly
discovered regulatory element ssDNA originating and accumulating from autonomous rolling
circle plasmid replication. B) Our experimental and theoretical data emphasize the importance
of the amount of long mRNA that correlates with the plasmid copy number, as well as the
presence of ssDNA as CsrA sequestering elements affecting the  cea-cel delay. C strains are
shown in black,  S strains  are  shown in grey. The grey  scatched area depicts  the  area of
expected delay times of all strains in dependence to the plasmid copy number only. Please
note that due to the fact that at low plasmid copy numbers many cells don't lyse (nl) these
delay times cannot be given as an exact value, but are estimated to lie in the depicted grey
area. Red dots represent the values of the theoretical analysis in the absence of ssDNA (so
plasmid  copy  number  effect  only),  green  markers  represent  the  theoretical  values  in  the
presence of ssDNA, which is the case for all C strains. 
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Supplementary Information (experimental) 
Accumulation of single-stranded DNA (ssDNA) 
Recently, Morales et al.(1), detected the accumulation of ssDNA in Escherichia coli cells 
carrying any one of the plasmids pColE3-CA38, pColE9 and pColE5. This ssDNA originates 
from rolling-circle replication(1, 2). This type of replication enables an autonomous plasmid 
to replicate independently of the bacterial cell cycle and cell division(3). The replicons of the 
plasmids pColE2-P9 and pColE3-CA38 are closely related(4), indicating that asymmetric 
rolling-circle replication(5) of the pColE2-P9 plasmid (Fig S5a) could also lead to ssDNA 
accumulation, as shown in Fig 3 and Fig S5b. Furthermore, sequencing of pColE2-P9 and an 
analysis of its homology with pColE3-CA38 (Table S1) confirms the close relationship 
between the two plasmids. The Rep protein binds to the ColE2 ori to initiate rolling-circle 
replication(3), leading to ssDNA synthesis(2). The concentration of the Rep protein is held 
constant by the action of an anti-sense sRNA (the inkA gene product) that binds to the 5'- 
untranslated region of the mRNA encoding the Rep protein(6).  
Please note that the reporter plasmid pMO3(7) used in this study is a derivative of pBAD24. 
Its replication mode(8) differs from that of pColE2-P9 and does not lead to the accumulation 
of ssDNA (Fig 3)(1). 
 
 
 
 
Supplementary Methods 
In the following, additional information relating to the construction of the specific mutant 
strains used in this study is given, together with a description of RNA and ssDNA oligos used 
for CsrA binding studies. Table S2 provides an overview of all (mutant) strains used in this 
study. Table S3 summarizes all primers used, including those employed in the construction of 
the mutant strains listed in Table S4 and in sequencing of pColE2-P9. Table S4 lists the base-
pair changes introduced into the plasmid pMO3 that resulted in plasmids pMO4, pMO5, 
pMO6, pMO7, as well as the sequences of RNA and ssDNA oligos used for CsrA-binding 
studies as described in the Methods section of the main text. 
 
 
 
 
Supplementary Tables 
Table S1: Sequence homology of genes present on the plasmids pColE2-P9 and pColE3-
CA38. Numbers in red indicate that the gene extends past the base-pair designated as position 
1. 
Gene Sequence position 
on pColicinE2-P9 
Sequence position 
on pColE3-CA38 
Homology 
E2/E3 
rep 3073-3792 3344-4258 97% 
ssi 4084-4159 4376-4451 100% 
mob 4182-4456 4475-4750 98% 
tra 4636-6757,1-98 4929-7118,1-30 97% 
incA 2943-3057 3214-3328 100% 
colE2/E3 ori 3966-3997 4257-4289 94% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2: Bacterial strains used in this study 
Bacterial strain Strain description Genetic modification/information Reference 
BZB 1011   (9) 
CWT                  
(BZB 1011 E2C) 
 Carries pColE2-P9 (9) 
CREP1 (EMO3-C) BZB 1011 E2C 
pMO3 
Carries pColE2-P9 and the reporter 
plasmid pMO3 
(7) 
SREP1 (EMO3-S) BZB 1011 pMO3 Same as EMO3-C without the 
Colicin E2 plasmid 
(7) 
LexA1 BZB 1011 pMO4 
Derivative of SREP1 
LexA binding sequence altered on 
pMO3 to achieve stronger LexA 
binding, resulting in pMO4 
This study 
LexA2 BZB 1011 pMO5 
Derivative of SREP1 
LexA binding sequence altered on 
pMO3 to achieve weaker LexA 
binding, resulting in pMO5 
This study 
CsrA1 BZB 1011 pMO6 
Derivative of SREP1 
CsrA binding sequence on pMO3 
altered to achieve stronger CsrA 
binding, resulting in pMO6 
This study 
CsrA2 BZB 1011 pMO7 
Derivative of SREP1 
CsrA binding sequence on pMO3 
altered to achieve weaker CsrA 
binding, resulting in pMO7 
This study 
CsrB 
(EMO3::CsrB) 
BZB 1011 
CsrB::Kan pMO3 
Derivative of SREP1 
CsrB::Kan, in-frame replacement of 
CsrB by a kanamycin resistance 
This study 
CsrC 
(EMO3::CsrC) 
BZB 1011 
CsrC::Kan pMO3 
Derivative of SREP1 
CsrC::Kan, in-frame replacement of 
CsrC with a kanamycin resistance 
This study 
CsrBC 
(EMO3::CsrBC) 
BZB 1011 
CsrB::Cam 
CsrC::Kan  pMO3  
Derivative of SREP1 
CsrC::Kan, CsrB::Cam, in-frame 
replacement of CsrC by a kanamycin 
resistance and of CsrB by a 
chloramphenicol resistance cassette 
This study 
CREP2 BZB 1011 E2C 
pMO8 
Same as CREP1, only the origin of 
replication on pMO3 has been 
changed to p15A to achieve a lower 
copy number of 13 copies per cell - 
pMO8 
This study 
SREP2 BZB 1011 pMO8 Same as SREP1, only the origin of 
replication on pMO3 has been 
changed to p15A to achieve a lower 
copy number of 13 copies per cell -> 
pMO8 
This study 
 
 
 
 
 Table S3: Primers used in this study. Primers P1-P12 were used for construction of the 
mutant strains listed in Table S2. Primers P13-P24 were used for sequencing pColE2-P9. 
Primer pairs P25/P26 and P27/28 were used to create the low copy plasmid pMO8. 
Name Sequence Purpose 
P1 5´- GACGGGTACTTTTTGTACTGTACATAAAACCAGTGG - 3´ LexA1 [fwd] cloning 
P2 5´- CCACTGGTTTTATGTACAGTACAAAAAGTACCCGTC- 3´ LexA1 [rev] cloning 
P3 5´- GACGGGTACTTTTTGATCCCTACATAAAACCAGTGG- 3´ LexA2 [fwd] cloning 
P4 5´- CCACTGGTTTTATGTAGGGATCAAAAAGTACCCGTC- 3´ LexA2 [rev] cloning 
P5 5´- GGCATTCTTTCACATTAAGGAGTCGTTATG - 3´ CsrA1 [fwd] cloning 
P6 5´- CATAACGACTCCTTAATGTGAAAGAATGCC- 3´ CsrA1 [rev] cloning 
P7 5´- GCATTCTTTCACAACAAGGATGTGTTATGAAAAAAATAACCGG-3´ CsrA2 [fwd] cloning 
P8 5´- CCGGTTATTTTTTTCATAACACATCCTTGTTGTGAAAGAATGC- 3´ CsrA2 [rev] cloning 
P9 5´GTGGTCATAAAGCAACCTCAATAAGAAAAACTGCCGCGAA 
GGATAGCAGG AATTAACCCTCACTAAAGGGCG 3´ 
ΔCsrB [fwd] cloning 
P10 5´TTGTCTGTAAGCGCCTTGTAAGACTTCGCGAAAAAGACGATTCTATCT
TCTAATACGACTCACTATAGGGCTC 3´ 
ΔCsrB [rev] cloning 
P11 5´ ACTGATGGCG GTTGATTGTT TGTTTAAAGCAAAGGCGTAA 
AGTAGCACCCAATTAACCCTCACTAAAGGGCG 3´ 
ΔCsrC [fwd] cloning 
P12 5´GCCGTTTTATTCAGTATAGATTTGCGGCGGAATCTAACAGAAAGCAA
GCATAATACGACTCACTATAGGGCTC 3´ 
ΔCsrC [rev] cloning 
   
P13 5´- ACCGTATCTCCGTCATCAAC -3´ ColE2-1 [fwd] sequencing 
P14 5´- CTTCCTGTGAGAACTGC -3´ ColE2-2 [fwd] sequencing 
P15 5´- GTAGCGAGCGAATGAG -3´ ColE2-3 [fwd] sequencing 
P16 5´- CATGATTGCCGATGTGG -3´ ColE2-4 [fwd] sequencing 
P17 5´- GTGGAATACGTGGATTGC -3´ ColE2-5 [fwd] sequencing 
P18 5´- GGAGAAGCTATAAACCATG -3´ ColE2-6 [fwd] sequencing 
P19 5´- TCTGCTCATGTTTGACAGCTT -3´ ColE2-7 [fwd] sequencing 
P20 5´- CTCTGTTCGCATGGTCAG -3´ ColE2-8 [rev] sequencing 
P21 5´- CACGTTCGATGTCGTTC -3´ ColE2-9 [rev] sequencing 
P22 5´- GAATACATTCTCACACGCTC -3´ ColE2-10 [rev] sequencing 
P23 5´- CGTTGTTGTTGCCTGTG -3´ ColE2-11 [rev] sequencing 
P24 5´- TCATCCGCCAAAACAGCC -3´ ColE2-12 [rev] sequencing 
   
P25 5´- ATTAAGTCGACGAAGATCCTTTGATCTTTTC -3´ pMO3_noORI SalI [rev]  
Cloning pMO3 vector 
without ORI  
P26 5´- ATTAAGCATGCAACGCCAGCAACGC -3´ pMO3_noORI SphI[fwd]  
Cloning pMO3 vector 
without ORI 
P27 5´- ATTAAGTCGACTTGAGATCGTTTTGG -3´ p15A ORI SalI [rev] 
cloning 
P28 5´- ATTAAGCATGCTTTCCATAGGCTCCG -3´ p15A ORI SphI [fwd] 
cloning 
 
 
 
 
 
 
 
 Table S4. Sequences of genetic elements. The first three rows depict sequence changes in 
the LexA binding site (two overlapping LexA binding SOS boxes) on the pMO3 reporter 
plasmid, leading to altered LexA binding (pMO4, pMO5). The following three rows show the 
changes made in the CsrA binding site within the second mRNA loop (which also includes 
the ribosome binding site of the cel gene and the GGA motif recognized by CsrA) that 
potentiate (pMO6) or weaken (pMO7) CsrA binding (Fig 2d). The following three rows list 
the sequences of RNA oligos used for CsrA binding studies (Methods, Fig 2d) and include 
the alterations in the CsrA binding site mentioned above. The last three rows give the 
sequences of the 89-bp ssDNA oligos used to study binding of CsrA to ssDNA by gel shift 
analysis (Methods). Bases highlighted in green correspond to sequence changes. Bases 
shown in boldface highlight the GGA motif required for CsrA binding as present within the 
second mRNA (plasmid), RNA oligo or ssDNA oligo loop. We confirmed the appropriate 
formation of secondary structures of these oligos using Mfold(10) (Methods). 
 
Name Sequence Description 
pMO3 5‘-TTGATCTGTACATAAAACCAGTGGTTTTATGTACAGTATTAA-3‘ LexA binding site 
pMO4 5‘-TTGTACTGTACATAAAACCAGTGGTTTTATGTACAGTATTAA-3‘ LexA binding site 
pMO5 5‘-TTGATCCCTACATAAAACCAGTGGTTTTATGTACAGTATTAA-3‘ LexA binding site 
pMO3 5' - CACAACAAGGAGTCGTTATG  - 3' CsrA binding site 
second loop 
pMO6 5' - CACAACAAGGATGTGTTATG - 3' CsrA binding site 
second loop 
pMO7 5' - CACATTAAGGAGTCGTTATG - 3'  CsrA binding site 
second loop 
RNA Oligo 
equivalent to 
sequence of 
pMO3 
5‘-Cy5- AUUUAAACAGGGCUGAAAUAUGAAUGCCGGUUGUUUAU 
GGAUGAAUGGCUGGCAUUCUUUCACAACAAGGAGUCGUUAUGA
AAAAAUA -3‘ 
RNA Oligo with 
both CsrA binding 
sites (GGA) 
RNA Oligo 
equivalent to 
sequence of 
pMO6 
5‘-Cy5- AUUUAAACAGGGCUGAAAUAUGAAUGCCGGUUGUUUAU 
GGAUGAAUGGCUGGCAUUCUUUCACAACAAGGAUGUGUUAUGA
AAAAAUA -3‘ 
RNA Oligo with 
both CsrA binding 
sites (GGA) 
RNA Oligo 
equivalent to 
sequence of 
pMO7 
5‘-Cy5- AUUUAAACAGGGCUGAAAUAUGAAUGCCGGUUGUUUAU 
GGAUGAAUGGCUGGCAUUCUUUCACAUUAAGGAGUCGUUAUG 
AAAAAAUA -3‘ 
RNA Oligo with 
both CsrA binding 
sites (GGA) 
ssDNA Oligo 
equivalent to 
sequence of 
pMO3 
5‘-Cy5- ATTTAAACAGGGCTGAAATATGAATGCCGGTTGTTTAT 
GGATGAATGGCTGGCATTCTTTCACAACAAGGAGTCGTTATG 
AAAAAAATA - 3‘ 
ssDNA Oligo with 
both CsrA binding 
sites (GGA) 
ssDNA Oligo 
equivalent to 
sequence of 
pMO6 
5‘-Cy5-ATTTAAACAGGGCTGAAATATGAATGCCGGTTGTTTAT 
GGATGAATGGCTGGCATTCTTTCACAACAAGGATGTGTTATG 
AAAAAATA -3‘ 
ssDNA Oligo with 
both CsrA binding 
sites (GGA) 
ssDNA Oligo 
equivalent to 
sequence of 
pMO7 
5‘-Cy5- ATTTAAACAGGGCTGAAATATGAATGCCGGTTGTTTAT 
GGATGAATGGCTGGCATTCTTTCACATTAAGGAGTCGTTATG 
AAAAAATA -3‘ 
ssDNA Oligo with 
both CsrA binding 
sites (GGA) 
 
 
 Supplementary Figures  
 
 
Fig S1: Dependence of the maximal fluorescence intensity, cumulative fraction and time-
point of expression start of cells expressing the ColicinE2 operon in the CREP1 and SREP1 
strains on the MitC concentration. Yellow: cea gene expression (colicin production), blue: 
cel gene expression (colicin release). Data shown here represent average values obtained from 
single-cell time-lapse microscopy experiments. A-C) CREP1, D-F) SREP1, A,D) Maximal 
fluorescence intensity of the cells that express the ColicinE2 operon. B,E) Cumulative 
fraction of cells expressing the ColicinE2 operon. C,F) Onset (tON) of cea and cel gene 
expression. 
 
 
  
Fig S2: Impact of alteration of the LexA binding site or absence of sRNAs on ColicinE2 
expression in SREP1 cells. A-C) Yellow: cea gene expression (colicin production), blue: cel 
gene expression (colicin release). A) Mean maximal expression of the colicin operon (relative 
to the SREP1 strain) in mutant reporter strains bearing altered LexA binding sites (LexA1 and 
LexA2, SI, Methods), or lacking the sRNA CsrB (CsrB), or missing both sRNAs CsrB and 
CsrC (CsrCB). B) Cumulative fraction of cells expressing the colicin operon. C) TON times 
for cea and cel gene expression. D) Delay between cea and cel gene expression. 
 
 
 
 
 
 
 
 
 Fig S3: Biochemical network involved in the post-transcriptional regulation of 
ColicinE2. The top part shows the complete network, involving all interactions and 
components considered in this work. This complex description of the network can be reduced 
to the set of effective interactions shown in the lower panel. The derivation of these effective 
descriptions is given in section 2 of the theory part of the SI. 
  
Fig S4: Effect of sRNA knock-out on Colicin E2 expression in long-term experiments 
(0.25 µg/ml MitC). To determine the importance of sRNA regulation for ColicinE2 
expression over a longer period, plate-reader experiments were performed as described in 
Methods. A) Absorbance, B) Fluorescence intensity of cells expressing cea (YFP, colicin 
production), C) Fluorescence intensity of cells expressing cel (CFP, colicin release). Red: 
SREP1 strain, Blue: CsrC single sRNA knock-out, Green: CsrB single sRNA knock-out, 
Black: CsrB/C double sRNA knock-out. 
 
  
Fig S5: ssDNA accumulation in bacteria carrying pColE2-P9 and binding of CsrA to 
ssDNA. A) Map of pColE2-P9. The plasmid map was created using Vector NTI Expression 
Version 1.6.0. The plasmid sequence can be accessed via Genbank accession number 
KY348421. B) Accumulation of ssDNA in CWT is independent of the presence of MitC. 
Agarose gel of plasmid and ssDNAs extracted from CWT. Lanes 1-3 and 9-11 were loaded 
with the indicated markers: 1-kb ladder, 7249-bp ssDNA ring (M13mp18), and 5386-bp 
ssDNA ring (PhiX174). Lane 4-8: uncleaved CWT DNA showing the 6800-bp pColE2-P9 
dsDNA (blue) and ssDNA (red) at different concentrations of the SOS inducing agent MitC. 
The staining substance ETBR binds optimal to dsDNA and only to ssDNA if secondary 
structures (ds part of ssDNA) are present. Hence, binding of ETBR to ssDNA is much lower 
than to dsDNA. Consequently, the brighter ssDNA bands reflect the high amount of ssDNA 
accumulated in the bacterial cells. C) Gel-shift analysis of CsrA binding to RNA or ssDNA 
oligos equivalent to the RNA corresponding to pMO3 (Methods, SI), verifying binding of 1 
or 2 CsrA molecules to single RNA and ssDNA oligos (first and second shift, respectively). In 
the first lane for comparison no CsrA is added. RNA or ssDNA was applied at 5 nM. D) 
Dissociation constants (Kd) for the binding of CsrA to various ssDNA oligos (SI). CsrA1 = 
stronger CsrA binding, CsrA2 = weaker CsrA binding. 
 
 
  
 
Fig S6: cea-cel delay-time distributions and average cea-cel delay-times for different 
ssDNA production rates and strains. The SREP1 strain does not produce ssDNA, and is 
plotted (in green) only for the purpose of direct comparison with the CREP1 strain. If no 
ssDNA is produced (D = 0), we find that the CREP1 strain shows a broader cea-cel delay-time 
distribution, compared to the cases with ssDNA production. The wild-type strain CWT does 
not lyse at all during the SOS signal for D = 0. If we increase the ssDNA production rate, we 
find the experimentally observed behaviour that the CREP1 strain shows very short cea-cel 
delays. In the wild-type strain, a certain threshold rate of ssDNA production is required to 
induce a significant level of lysis, emphasizing the importance of ssDNA for toxin release. 
Ensemble size: 2000 realisations. 
 
 
 
 
 
  
Fig S7: Average of the time evolution of the CsrA and long mRNA abundance for 
different ssDNA production rates and strains. Between t=200 and t=500, the system is 
subject to an SOS signal. In all cases, the SOS signal initiates a decrease in CsrA abundance 
from a previously stable level. This level is determined by the production, binding, and 
degradation rates of CsrA and its complex partners. As higher CsrA levels take longer and are 
also less likely to decrease to zero, they also directly affect the duration of the average cea-cel 
delay-time. The three plots for D = 0 also show a single trajectory of long mRNA and CsrA 
in light green and light red, respectively. Ensemble size: 2000 realisations. 
 
 
 
 
 
  
Fig S8: Cell lysis after induction with 0.25 µg/ml MitC. CREP1 lyses on average 87 (± 3.9) 
min after induction with MitC, CWT lyses considerably later at 150 (± 6.9) min. For CREP1, 
mean cell lysis nearly coincides with the TONcea at 69.71 ± 0.77 min(7) (red line). This 
interval between TONcea constitutes the delay between the SOS signal (MitC induction) and 
the start of cea gene expression. In our theoretical model, this initial delay is very short, as 
the system here switches directly from the pre-SOS signal 'OFF' state into the post-SOS 
signal 'ON' state. Hence, the red line also depicts the time-point of this switch (0 min in Fig 
4). 
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Supplementary Information (Theory):
Theoretical Model for ColicinE2 Expression
Including the Additional CsrA Sequestering
Element ssDNA
1 The biological system
The biological phenomenon we wish to describe by means of a quantitative
theoretical model is the regulation of ColicinE2 release in E. coli. ColicinE2
is a bacterial toxin encoded by the gene cea, which is part of the ColicinE2
operon located on a plasmid. This operon also contains genes for an
immunity protein (cei gene) and a lysis protein (cel gene). The lysis protein
is part of the operon as cell lysis is the only way to release the toxin
into the environment. Since lysis also means the death of the cell, the
release of ColicinE2 is highly regulated. Previous studies have revealed the
regulatory components controlling ColicinE2 production and release on
both the transcriptional and post-transcriptional levels:
• The transcription of the operon is regulated by the repressor LexA,
which is part of the E. coli SOS response regulatory network [1, 2].
Stressful events, such as DNA damage activate a SOS response sys-
tem [1], which stochastically triggers the transcription of the operon
by degradation of LexA. Once transcription starts, two mRNA tran-
scripts are produced: short mRNA, containing only the toxin and
immunity protein, and long mRNA, which contains also the lysis
protein [3].
• The post-transcriptional regulation (see Fig. 1 and also Fig. S3) acts
on the long mRNA only. To our knowledge, its only regulator is
the protein CsrA, which binds to the Shine-Dalgarno sequence that
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is located on the long mRNA between the sequences coding for the
immunity and lysis proteins [3]. When a CsrA protein binds to long
mRNA and thus forms a complex with it, the gene for the lysis
protein can no longer be translated, and thus the cell does not lyse [3].
By preventing lysis protein expression, CsrA regulates the release of
ColicinE2. The abundance of CsrA itself is known to be regulated
by the two CsrA-sequestering short RNAs (sRNAs) CsrB and CsrC,
which both have several CsrA binding sites [4, 5]. Our current study
suggests that, in addition, rings of single-stranded DNA (ssDNA)
also sequester CsrA, and therefore represent a novel CsrA regulator.
This ssDNA is created as an intermediate during the rolling circle
replication of the ColicinE2 plasmids.
A particular example for the importance of these regulatory interactions is
the delay between production and release of ColicinE2, which has recently
been studied experimentally [6]: The translation of lysis proteins from
long mRNA (and therefore lysis itself) can only start if there are free long
mRNAs, that is, long mRNAs that are not bound to CsrA. From what
is known about CsrA interactions, we assume in our biochemical model
that a CsrA molecule can no longer regulate long mRNA when it is either
sequestered, or degraded. Previous studies [7] show that CsrA is highly
abundant during growth phase, mainly in form of CsrA complexes. When
an SOS response is triggered, however, the production of long mRNA
increases such that free CsrA abundance decreases, and eventually lysis
proteins are translated from free long mRNA. This process does not happen
instantaneously: Due to stochasticity in the SOS response system and the
time it takes to produce, bind or degrade the regulatory components
involved, we find a delay between the expression of the unregulated cea
gene (part of the short mRNA) and the CsrA-regulated cel gene (part
of the long mRNA). This delay is presumably not just a byproduct of
regulation, but has also a biological function: It gives the cell time to
accumulate ColicinE2, and thus allows for higher toxin concentrations
upon the release. Moreover, it presumably also acts as a safety buffer,
which prevents premature cell lysis, for instance due to fluctuations in the
system [6].
In contrast to the abundances of the regulatory components, the cea-cel-
delay is a quantity that can readily be measured experimentally by reporter
plasmids inserted in the E. coli cells. These reporter plasmids carry the
ColicinE2 operon, but the toxin (cea) and lysis (cel) gene are replaced by two
different fluorescence protein genes (CFP and YFP). Since only these two
3
number of number of
strain reporter plasmids pColE2P9 plasmids ssDNA
SREP1 ≈ 55 – –
SREP2 ≈ 13 – –
CREP1 ≈ 55 ≈ 20 accumulates
CREP2 ≈ 13 ≈ 20 accumulates
CWT – ≈ 20 accumulates
Table S5: The five different strains and the abundance of the genetic
elements that differentiate them [8].
genes are replaced, the reporter plasmids have the same promoter as the
ColicinE2 plasmid, and the long mRNA transcript of the reporter plasmid
has the same CsrA binding site as the original long mRNA. Consequently,
a reporter plasmid behaves like the ColicinE2 plasmid, but produces two
types of fluorescence proteins instead of toxin and lysis proteins. Therefore,
upon introducing reporter plasmids to an E. coli cell, one can measure the
time points of production of the corresponding fluorescence proteins; these
measured time points then coincide with the time points of toxin and lysis
protein production. In this study, we use two reporter plasmid types, which
differ by their mean abundance in the cell: type 1 (pMO3) accumulates
to about 55 plasmids per cell, whereas type 2 (pMO8) only to about 13
plasmids per cell.
With three different plasmid types, the original and the two reporter
plasmids, we can construct five different strains (see also Table S5): First,
the wild-type strain, CWT, which carries only ColicinE2 plasmids. Inserting
reporter plasmids to this strain creates, depending on the reporter plasmid
type inserted, either a strain called CREP1 or a strain called CREP2. Com-
pletely replacing the ColE2 plasmid with one of the reporter plasmid types
creates another two strains, referred to as SREP1 and SREP2. Our experiments
show that the plasmid types also differ in the production of ssDNA: cells
carrying the ColicinE2 plasmid do accumulate ssDNA (see Fig. 3), while
this is not the case for the SREP1 and SREP2 strain cells, which only contain
reporter plasmids (see Fig. 3 and Supplementary Information).
As discussed in detail in section 2, we will use mathematical modelling
to infer the delay of the wild-type strain from the delay measured in
the other strains containing the reporter plasmid. Before doing so, we
recapitulate the main experimental findings on the delay-times in the
bacterial strains containing the reporter plasmid.
In our experiments (see main text) we found that the CREP1 strain shows
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no significant delay between cea and cel gene expression, whereas the SREP1
strain has a significant mean delay of 75 minutes. Moreover, we observed
that the SREP1 strain has a broad delay-time distribution around this mean
value. This raised the question as to the source of this difference. The CREP1
and SREP1 strains differ only in their plasmid composition and are both
genetically identical (see Table S5). From this we conclude that the presence
of ColicinE2 plasmids in the CREP1 strain introduces further regulatory
elements (compared to the reporter plasmids), which are responsible for
the shorter cea-cel delay times compared to the SREP1 strain. The reporter
and the ColicinE2 plasmids contain the same regulatory sequences (see
Methods), which means that the additional regulatory elements cannot be
different mRNA transcripts specifically produced by the ColicinE2 plasmid.
From what is known about the two plasmids and the regulatory network
of ColicinE2 (see above), two mechanisms could in principle account for
the shorter delay times in CREP1, which are: First, additional production
of CsrA sequestering long mRNA due to the larger plasmid copy number,
and second, the accumulation of ssDNA which, as our study shows, can
also sequester CsrA.
2 Mathematical model of the ColicinE2 release
In the following, we develop a mathematical model that enables us to in-
vestigate the regulation of ColicinE2 release in all five strains (CREP1, CREP2,
CWT, SREP1, and SREP2). The model accounts for all necessary regulatory
components, including the ssDNA and the different plasmid compositions.
We validate this model by reproducing the experimentally observed delay
time distributions for the SREP1 strain. Variation of ssDNA production in
the model then allows us to quantify the impact of ssDNA production and
plasmid copy number on the cea-cel delay. Moreover, the model enables
us to infer the behaviour of the CWT strain, for which the cea-cel delay
cannot be directly measured experimentally. The inferred behaviour can be
validated by comparison with experimentally measured lysis times, see Fig.
S8.
Several experimental studies defined and probed the regulatory net-
works and components involved in E. coli SOS responses, as well as Col-
icinE2 production and release [3, 8, 6, 1]. Starting from these experimental
results, the regulatory interactions have also been studied using mathemat-
ical models [2, 9, 10, 11]: For the transcriptional regulation network of the
E. coli SOS response system, a stochastic model has been presented, which
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is able to reproduce the distribution of stochastic SOS activity peaks [2].
For the post-transcriptional regulation of ColicinE2 release, we recently in-
troduced a hierarchical three-component model [9] involving long mRNA,
CsrA, and an effective sRNA. This model was also combined with the
stochastic SOS signal model from Ref. [2] to emulate the response of
ColicinE2-producing bacteria to external stress. With this combined ap-
proach, the model shows that sRNA reduces internal fluctuations and helps
controlling the level of CsrA. Moreover, the model predicts stochastically
distributed delays between SOS signal and lysis, which is also seen in
experiments with the SREP1 strain.
In this section, we extend our previous model [9], taking into account
the new experimental findings presented in the main text. In particular,
we incorporate the additional regulator ssDNA as well as the different
plasmid copy numbers and types. For this step, it is important to know
the derivation of the previous, three-component model, which is why we
outline the derivation of the previous model as we develop our new model
from scratch. For a detailed derivation of the three-component model, we
refer the reader to Ref. [9].
2.1 Regulatory network
Our goal is to design a stochastic model that enables us to investigate the
dynamics of the regulatory networks involved the SOS response and the
ensuing synthesis and release of ColicinE2. To this end, we first formulate
the interactions of the regulatory components as a set of (deterministic)
differential equations, that is, as a mass-action model. This approach
disregards any spatial effects and considers the system as well mixed.
Extending our previous study [9], we build a mass-action model for the
SOS response, and the regulatory network for ColicinE2 production and
release from the following assumptions and properties of the components
(see also Fig. S3):
• The abundances of long mRNA, CsrA and effective single-binding-
site sRNA (see below) are denoted by M,A and S, respectively. These
abundances give the number of free components, that is, the number
of long mRNA, CsrA and sRNA molecules that are not bound in
a complex. Moreover, PCOL and PREP denote the copy number of
ColicinE2 and the reporter plasmids, respectively (there is no need to
distinguish between the two reporter plasmid types for PREP as they
do not occur in the same cell at the same time).
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• The response to external stress (“SOS response”) is regulated by the
LexA/RecA system [1], which we incorporate into our model using
the differential equations given in Ref. [2]. This model accounts for
the production, degradation and (un)binding of the proteins LexA
(L) and RecA (R), the mRNAs they are translated from (Ml and Mr,
respectively), as well as the number of repressed promoters control-
ling the transcription of these mRNAs (Bl and Br, respectively). In
this system, LexA acts as repressor: as long as a LexA protein is
bound to the promoter region of the RecA or LexA operon, no mRNA
is produced. The number of repressed RecA and LexA promoters
increases if LexA binds to an unrepressed promoter, and decreases as
it unbinds. Therefore, the differential equations for Bl and Br contain
two terms each: a production term proportional to the abundances of
LexA and unrepressed promoters, and a degradation term propor-
tional to the number of repressed promoters. In an E. coli cell, there
is only one promoter for each LexA and RecA, which means that Bl
and Br can take either the values 0 or 1. The differential equations
then read
∂tBr = k
+
r (1 −Br)L− k
−
r Br, (1)
∂tBl = k
+
l (1 −Bl)L− k
−
l Bl, (2)
where the k± denote the attachment and detachment rates of LexA
to/from the promoter indicated by the subscript. From unrepressed
promoters the respective mRNA is transcribed, and hence, the mRNA
production depends linearly on the number of unrepressed promoters.
Once produced, the mRNA can spontaneously degrade. Therefore,
the differential equations for the mRNAs also contain two terms each,
and read:
∂tMr = αMr(1 −Br) − δMrMr, (3)
∂tMl = αMl(1 −Bl) − δMlMl, (4)
where α and δ give the per capita production and degradation rate
of the component indicated by the subscript. These mRNAs are
translated to RecA and LexA proteins, respectively. Hence, the pro-
duction terms of the two proteins are proportional to the respective
mRNA abundance. The number of proteins decreases by spontaneous
degradation. As the abundance of RecA is only affected by these two
processes, its differential equation reads:
∂tR = αRMr − δRR, (5)
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where αR and δR denote the per capita production and degradation
rate of RecA. Since LexA acts as regulator in the LexA/RecA-system,
its abundance is also affected by the interactions with the promoters.
Consequently, the terms from eqs. (1) and (2) appear in the differen-
tial equation for LexA, but with opposite sign. Moreover, in case of an
SOS signal, RecA depletes LexA, motivating an additional degrada-
tion term bilinear in L and R, with the degradation constant cp. Apart
from these interactions with the LexA/RecA-system, LexA is also
the repressor of the colicin operon. Therefore, the LexA/RecA SOS
response system interacts with the regulatory system of ColicinE2
production and release via B, the number of repressed promoters of
the ColicinE2 operon. Its differential equation contains two terms
analogous to the LexA and RecA promoters:
∂tB = k
+
P (PCOL + PREP −B)L− k
−
PB, (6)
where the k±P denote the attachment and detachment rates of LexA
repressor to/from the ColicinE2 promoter. Unlike Br and Bl, B
can take values between 0 and PCOL + PREP. The terms from eq. (6)
apppear, again with opposite sign, also in the differential equation
for LexA, which, altogether, reads
∂tL = αLMl − δLL− k
+
l (1 −Bl)L+ k
−
l Bl − k
+
r (1 −Br)L
+ k−r Br − k
+
P (PCOL + PREP −B)L+ k
−
PB− cpRL, (7)
where αL and δL give the per capita production and degradation
rate of LexA. For a detailed discussion of these equations, we refer
to Ref. [2]. Note that the SOS response system, eqs. (1)-(7), interacts
with the ColicinE2 regulatory network only through the parameter B
(see also next bullet point).
• The total production rate of long mRNA in the cell is proportional
to the number of unrepressed ColicinE2 promoters in the cell. This
number is given by the total number of plasmids in the cell, PCOL +
PREP, minus B, the number of promoters with the repressor LexA
bound to it. Hence, the production rate of long mRNA reads
αM(PCOL + PREP −B), (8)
where αM is the production rate per unrepressed promoter. Note
that considering different plasmid types generalizes our earlier work
presented in Ref. [9].
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• CsrA is produced at a constant rate, αA.
• The ColicinE2 system has two different regulatory sRNAs: CsrB
and CsrC. Apart from having different numbers of CsrA binding
sites and slightly different half-lifes, their mode of binding with
CsrA is very similar. Hence, we assume that we can describe their
regulatory impact by a single effective sRNA with corresponding
effective parameters (see Ref. [9] for details). Using effective sRNAs
in a mathematical model is indeed supported by experiments, which
show that the knock-out of either CsrB or CsrC causes a compensating
overproduction of the other sRNA (see the main text, and Ref. [5]).
This compensation is a natural consequence of a positive regulatory
effect of CsrA abundance to sRNA production (see bullet point below),
and highlights the functional equivalence of CsrB and CsrC. In Ref. [9]
we also showed that this effective sRNA, which contains N ≈ 10 CsrA
binding sites is equivalent to N effective single-binding-site sRNAs. This
drastically reduces the mathematical complexity of the model.
• Several studies found that the production of CsrB and CsrC is in-
directly regulated by the abundance of CsrA via the BarA/UvrY-
system [3, 4, 5]. Since the details of this interaction are largely un-
known, we model this positive regulation with an sRNA production
rate that is a linear function of the CsrA abundance. In addition to
this linear term, we also introduce a constant baseline production
term, since studies show that sRNAs are also produced (at very low
levels) in the absence of free CsrA [5]. Both production terms contain
a factor N, as we consider effective single-binding-site sRNAs in our
model (see the previous bullet point). The production term of the
effective single-binding-site sRNAs thus reads
αS,0N+αS,cA ·N,
with the baseline production rate αS,0, the linear coupling coefficient
αS,c, and the abundance of CsrA proteins A. Note that we did
not consider the positive feedback of CsrA on sRNA production in
Ref. [9].
• The degradation rates of long mRNA, CsrA and the effective sRNA
are each proportional to their respective abundance, and read δMM,
δAA and δSS, respectively.
• CsrA can bind to both long mRNA and the effective sRNA, and thus
forms CsrA-long mRNA and CsrA-sRNA complexes (CMA and CSA,
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respectively). In line with previous studies [12, 13] and our three-
component model [9], we assume that the formation and disassembly
of these complexes is much faster than the other processes involved in
post-transcriptional regulation. Therefore, we can employ adiabatic
elimination, ∂tCMA ≡ 0 and ∂tCSA ≡ 0. In Ref. [9], we show that this
enables us to combine the formation, disassembly and degradation
of the complexes into effective binding parameters, kM and kS. As
a consequence, we can solve for the complex abundances, CMA and
CSA, and eliminate them from our set of differential equations (see
Ref. [9] for details).
• The precise mechanism for the degradation of CsrA-sRNA and CsrA-
long mRNA complexes is not known. Here, we assume that CsrA
dimers are always degraded once their complex partner is degraded (in other
words: CsrA cannot “survive” the degradation of its partner).
• CsrA is a main regulator in growing E. coli cells, which is known
to bind to over 700 different targets [14, 15]. In the Supplementary
Information of Ref. [9] we show how one can eliminate the many
targets of CsrA to obtain a reduced system, which contains only the
components that are changed by the processes the model focusses
on (in this case: SOS-induced production and release of ColicinE2).
In the mathematical model presented in this section, we reduce the
system to three CsrA targets: long mRNA, sRNA, and (see below)
ssDNA. In agreement with experiments [7], the production rate of the
effective sRNA is large compared to the production of long mRNA
and ssDNA, such that the vast majority of sequestered CsrA proteins
is bound to sRNA.
• The short mRNA is not regulated by CsrA, and hence not part of the
regulatory network. However, our experiments use the translation
of short mRNA (specifically, the translation of the cea gene) as proxy
for promoter activity in the SREP1, SREP2, CREP1, and CREP2 strain.
To enable the experimental validation of our model, we include the
production of short mRNA in our model. Due to the lack of regulation,
the corresponding differential equation is decoupled from M,A and
S, and reads (with ∂Mshort∂t ≡ ∂tMshort)
∂tMshort = αMshort − δMshortMshort, (9)
where αMshort and δMshort are the rate constants for production and
per-capita degradation, respectively.
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The properties and assumptions of the SOS response and the ColicinE2
regulatory system we listed above have already been used (if not stated oth-
erwise) in the combined model for SOS response and ColicinE2 regulation
presented in Ref. [9].
ssDNA as regulatory component: In the main text, we show experi-
mentally that single-stranded DNA (ssDNA) serves as a component of
post-transcriptional regulation of ColicinE2 production and release. Since
this is a novel and, so far, an undocumented role of ssDNA, we briefly
discuss how it acts as a regulator for CsrA in an E. coli cell.
ssDNA is an intermediate in the rolling circle replication mechanism
of the ColicinE2 plasmid: The plasmid consists of double-stranded DNA
(dsDNA). The first step in its replication is the production of a ring-shaped
ssDNA transcript. These transcripts are produced both in absence and
presence of an SOS signal (Fig. S5), which means that ssDNA production is
constant. It is assumed that once a ring of ssDNA is completed, it detaches
from the plasmid and diffuses freely through the cell. During this time,
it is converted to double-stranded DNA, which eventually results in a
new plasmid. Between the detachment of the single-stranded ring and the
formation of a new plasmid, the ssDNA acts as a regulator of CsrA: Since
the ssDNA includes the coding sequences present in the long mRNA, CsrA
can bind to the Shine-Dalgarno sequence of the cel gene located on the
ssDNA, and thus forms an ssDNA-CsrA complex. This allows the ssDNA
to regulate free CsrA levels by sequestration, similar to the CsrA regulation
by sRNA.
In our mathematical model, we account for these properties of ssDNA
as follows:
• The production rate of ssDNA is assumed to be proportional to the
number of ColicinE2 plasmids, PCOL, as it is an intermediate product
of the rolling circle replication mechanism of the ColicinE2 plasmid.
It reads
αD · PCOL, (10)
with the per plasmid production rate constant αD.
• The degradation of ssDNA is proportional to the ssDNA abundance,
D, and thus reads
δD ·D, (11)
with the per capita degradation rate constant is δD.
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• The ssDNA has two binding sites for a CsrA dimer (see Methods of
the main text), and thus can form a complex, CDA, with it. Com-
plex formation occurs with rate k+D, and the complexes dissociate
into ssDNA and a CsrA dimer with rate k−D. Apart from disassem-
bly, we also include the possibility that a CsrA-ssDNA-complex can
spontaneously degrade (meaning that both CsrA and ssDNA are
degraded at the same time) by introducing the per capita rate δDA.
The abundance of complexes is denoted by CDA.
Taken together, we can now formulate a set of differential equations, which
allows us to quantify these interactions. These interactions are also illus-
trated as a biochemical network in Fig. S3.
We begin with the differential equation for the time evolution of the
long mRNA, M. From the properties collected above, we conclude that this
equation must contain three terms: The first term describes the produc-
tion of long mRNA, which is proportional to the number of unrepressed
promoters. This number is calculated from the difference between the
total plasmid copy number, PCOL + PREP, and the number of repressed
promoters, B. The abundance of long mRNA is reduced by a second and a
third term: The second term describes the spontaneous degradation of long
mRNA, and is proportional to its abundance, M. The third term is bi-linear
(that is, it is proportional to A and M) and represents the effective coupled
degradation of long mRNA in complexes with CsrA. This term combines
the binding of CsrA to long mRNA, the dissociation of this complex, and
its degradation in an effective binding parameter kM. The three terms read:
∂tM = αM(PCOL + PREP −B) − δMM− kMM ·A. (12)
The derivation of the effective coupled degradation in the third term is
described in detail in Ref. [9]; an analogous derivation for the ssDNA is
given below. The B in the first term is determined by the LexA/RecA
subsystem of the SOS response, in particular by eq. (6).
The differential equation for the time evolution of the effective single-
binding-site sRNA, S, consists of terms very similar to that for long mRNA.
Two terms account for spontaneous and effective coupled degradation,
respectively, and are structurally the same as in eq. (12). This is due to
the fact that the sRNAs regulate CsrA in the same way as CsrA regulates
the long mRNA, by forming complexes. The production term is, however,
different, and contains two parts: The first part, αS,0, describes a constant
baseline production, which ensures the production of sRNAs in the absence
of CsrA. The second part depends linearly on the abundance of free CsrA,
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and thus accounts for the positive regulatory function of CsrA for the
sRNAs. Taken together, these four terms give the differential equation for
S:
∂tS = αS,0N+αS,cN ·A− δSS− kSS ·A. (13)
Having described the two partners of CsrA, we now turn to the dif-
ferential equation for CsrA itself. Again, this equation has a very similar
structure to eqs. (12) and (13): An, in this case constant, production term,
as well as a term for spontaneous degradation. Here, however, we have
more than one coupled degradation term, since CsrA can bind to more
than one component: long mRNA (M), sRNAs (S), and ssDNA (D). The
effective coupled degradation terms for long mRNA and sRNA are ex-
actly the same as in eqs. (12) and (13), respectively. This reflects the fact
that the formation of a long-mRNA/CsrA- or sRNA/CsrA-complex has
for both complex partners the same consequence, that is, it reduces the
abundance of free CsrA by 1. The coupled degradation part is also re-
sponsible for the hierarchical regulation, which we discussed in [9]: The
actual regulation target, long mRNA (M), exclusively binds to CsrA; the
sRNAs affects the free long mRNA level only indirectly by sequestering
the CsrA and thus “regulating the regulator”. Moreover, we also have
to account for ssDNA/CsrA-complexes. Since we have not derived an
effective coupled degradation for this complex yet, we explicitly account
for its formation and disassembly. This means that we have to include
two terms that account for the decrease of free CsrA due to the formation
of ssDNA/CsrA-complexes and the increase of free CsrA when such a
complex disassembles. Altogether, the differential equation for CsrA reads
∂tA = αA − δAA− kMM ·A− kSA · S− k+DD ·A+ k−DCDA, (14)
where CDA is the abundance of ssDNA/CsrA-complexes, and k±D the
complex binding and disassembly rate, and the terms containing the novel
regulator ssDNA are highlighted in red. Note that we consider the ssDNA
to have only one binding site for CsrA in our model. We account for the
second binding site analogously to the many binding sites of the sRNA,
that is by assuming D to be an effective, single binding site ssDNA, with
an effective production rate fitted to experimental data.
The two ssDNA terms highlighted in red also appear in the differential
equation for D, since the formation and disassembly of ssDNA/CsrA-
complexes in- and decreases also the abundances of ssDNA. The sponta-
neous degradation is accounted for by a separate degradation term, already
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known from the differential equations of the other components. The pro-
duction term of ssDNA is proportional to PCOL, the number of ColicinE2
plasmids in the cell, since ssDNA is an intermediate of the ColicinE2
plasmid replication. The differential equation for ssDNA therefore reads
∂tD = αDPCOL − δDD− k
+
DD ·A+ k−DCDA. (15)
We are still left with the dynamics of the ssDNA-CsrA-complexes, CDA.
The “production” term of the ssDNA/CsrA-complexes is the binding term
already known from eqs. (15) and (14), but in this case with a positive sign.
The number of complexes is reduced by complex disassembly, which is
accounted for by the term k−DCDA that also appears in eqs. (15) and (14)
with a different sign. Apart from complex disassembly, the complexes can
be degraded (in the sense that the complexes and their components are
destroyed) spontaneously, which is given by a spontaneous degradation
term. Taken together, the differential equation for ssDNA reads
∂tCDA = k
+
DD ·A− k−DCDA − δCDACDA. (16)
Effective coupled degradation of ssDNA and CsrA: In the discussion
of the ssDNA properties, we saw that ssDNA also has a Shine-Dalgarno
sequence, just as the long mRNA. This suggests that we can make the
same assumptions for the CsrA-ssDNA-complex as we did for the CsrA-
long-mRNA-complex. In the following, we proceed analogously to the
simplification of the hierarchical three component model (see Ref. [9]), and
assume fast dynamics of complexes. Adiabatic elimination (∂tCDA ≡ 0)
yields
CDA =
k+DDA
k−D + δCDA
=
kDDA
δCDA
, (17)
with the effective binding parameter
kD :=
k+DδCDA
k−D + δCDA
.
By inserting eq. (17) into eqs. (14)-(16), we get our final set of differential
equations, which includes all four components:
∂tM = αM(PCOL + PREP −B) − δMM− kMM ·A, (18)
∂tS = αS,0N+αS,cN ·A− δSS− kSS ·A, (19)
∂tA = αA − δAA− kMM ·A− kSS ·A− kDD ·A (20)
∂tD = αDPCOL − δDD− kDD ·A. (21)
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The new regulative component ssDNA acts in the same fashion as the
sRNA by binding CsrA. Compared to the original three component system,
eqs. (12)-(14), the extension with ssDNA therefore resulted in a system
of equations with the same types of terms (source term, spontaneous
degradation, coupled degradation). We use eqs. (18)-(21) to study gene
expression dynamics for all three different strains. This is done by adjusting
the corresponding values for PCOL and PREP, see section 3. Moreover, we
investigate the impact of ssDNA on the regulation of ColicinE2 production
and release.
3 Parameter values
For the parameters associated with long mRNA, CsrA and the effective
sRNA, we adjusted the values that we determined in our previous study
([9]) according to new measurements. In particular, they were chosen such
that they are in accordance with our own experimental measurements (kM
and kS) or other studies (see below). In particular, the rates read (given
per E. coli cell volume, and using the shorthand notation “#” for molecule
numbers):
rate const. value unit description
αM 0.05 min−1 production of long mRNA
αS,0N 0.1 min−1 baseline production of eff. sRNA
αS,cN 0.07 min−1·#−1 production factor of eff. sRNA
αA 4.5 min−1 production of CsrA
δM 0.04 min−1·#−1 degradation of long mRNA
δS 0.023 min−1·#−1 degradation of effective sRNA
δA 0.00007 min−1·#−1 degradation of CsrA
kM 0.007 min−1·#−2 eff. binding of CsrA to long mRNA
kS 0.011 min−1·#−2 eff. binding of CsrA to sRNA
The three degradation rates (δM, δS, δA) were determined in previous,
experimental studies [7, 5]. The production rates (αA,αS,c,αM) were
fitted such that they reproduce component abundances from experimental
studies [7]. The baseline production for the sRNAs, αS,0N, is set to a low
value, as only few sRNAs are produced in the absence of CsrA [5].
In Ref. [9] we showed that a Poisson-distributed plasmid copy number
gives very similar results to a fixed plasmid copy number. This is due
to the fact that plasmid replication happens on larger timescales than the
regulatory interactions considered in our model. We retain this simplifying
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assumption, and set the number of ColicinE2 plasmids constant at PCOL =
20, which is the average value [8]. For the reporter plasmids in the CREP1,
CREP2, SREP1 and SREP2 strains, we take for type 1 the average copy number
PREP = 55 [16], and for type 2 the average copy number PREP = 13, which
we both also assume constant.
Adding ssDNA dynamics to the system introduces three new effective
rates, αD, δD, and kD. We assume that the ssDNA and the mRNA are
equally stable, and therefore use the same degradation rate constants for
both:
δD ≡ δM = 0.04 min−1 · #−1.
In combination with the KD-value measurements for ssDNA we could
determine the coupled degradation constant to
kD = 0.0001 min−1 · #−2.
Finally, we have to define the value for the production rate constant of
ssDNA, αD, which has not been explicitly measured yet. However, our
experimental data suggests that ssDNA accumulates abundances about
an order of magnitude larger than long mRNA. From fitting the ssDNA
production to this rough abundance relation, and also to measured delay-
times, we obtain
αD = 7 min−1 · plasmid−1.
To study the influence of ssDNA on the cea-cel delay, we varied the value
of αD between 0 and 9, see Fig. S6 and S7. For the validation of our model,
we also tested various values of αS,c and αM (data not shown). These tests
showed that, in general, the model is robust to parameter variations, in the
sense that changing a parameter value by a few percent only had minor
consequences for the resulting delay times and component abundances.
4 Simulation results
The differential equations eqs. (18)-(21) give, in combination with the
SOS response model, eqs. (1)-(7) (see [2]), a description of the regulatory
interactions governing ColicinE2 production. They enable us to study
steady states and the deterministic dynamics of gene expression for all five
strains. However, the SOS response [2] shows an inherent stochasticity:
The ColicinE2 promoter is not activated permanently during an SOS signal,
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but in stochastically appearing bursts of activity. Moreover, most of the
regulatory components like long mRNA occur in low abundances, such that
also intrinsic demographic fluctuations in the ColicinE2 regulatory system
become important. We can study stochastic effects like these by formulating
the deterministic dynamics described in eqs. (1)-(7) and eqs. (18)-(21) as a
stochastic process. To this end, we consider each component (M,S,A andD,
as well as the components of the SOS response system) as random variables
that are changed by stochastic events like production or degradation of
molecules. Each of these events occurs at an average rate that equals the
corresponding term in the mass action model. For instance, the effective
coupled degradation of a long mRNA and CsrA happens at a rate kMM ·A
(see eq. (18)), which decreases both the abundance of long mRNA (M)
and the abundance of CsrA (A) by 1. By defining all remaining stochastic
production, degradation and binding events in the system this way, we
obtain a description of the SOS response and ColicinE2 regulatory system
as a stochastic (Markov) process. We then use the Gillespie algorithm [17] to
implement the stochastic process as a stochastic simulation. This simulation
enables us to produce stochastically correct realisations of the temporal
evolution of the system’s random variables. The results from sufficiently
large ensembles of these realisations is then the basis for the validation of
the theory by experimental data.
In our simulations, we followed the scheme already developed in
Ref. [9]: We initiate the system in a non-SOS state, where the parame-
ter cp in eq. (6) of the SOS response system (see also Ref. [2]) is set to 0, that
is, RecA does not cleave LexA. Therefore, B, the number of unrepressed
promoters, is low (1 for SREP2, 2 for CWT, 3 for CREP2, 4 for SREP1, and 5 for
CREP1). After 200 minutes, we mimic the effect of an SOS signal by increas-
ing the parameter cp, such that RecA catalyses the degradation of LexA,
which acts as repressor for the ColicinE2 operon. This has the effect that
the production of both long and short mRNA immediately increases. The
SOS signal is stopped again at t = 500 minutes. For each set of parameters,
this scheme is repeated 2000 times in order to obtain an ensemble of 2000
realisations.
To be able to compare these simulation results with experiments, we
have to give an appropriate definition of the cea-cel delay in the simulations.
As the beginning of “cea expression”, we define the point in time at which
the short mRNA level rises to two times its value before the SOS signal
started. Our simulations show that the CsrA abundance decreases during
the SOS signal, as more CsrA-sequestering long mRNA is produced. Once
there is no free CsrA left, we find free long mRNA in the system. We
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define the first point in time at which more than 8 free long mRNAs exist
in the system as “cel expression”. This definition accounts for the fact
that in general fewer lysis proteins are produced than toxin proteins [8].
In the experiment, the expression of cea and cel are defined by the point
in time the respective fluorescence intensity reaches five times its basal
(i.e. pre-SOS) level. Therefore, the expression times are determined by the
appearance of proteins in the experiment, but by the appearance of mRNAs
in the stochastic simulations. We choose the different definition of the delay
in the simulations, as the specific biochemical rates of many processes
involving the mRNAs and proteins are largely unknown, and have to be
fitted according to observed abundances. If we included the translation
of short and long mRNA to toxin, lysis and fluorescence proteins used
in the experimental study into our model as well, we would add several
new parameters that require fitting to our mathematical model, without
getting a more precise definition of the thresholds that determine the delay.
Moreover, comparing a delay in the production of mRNAs with a delay
in the production of proteins is valid in our case, since both fluorescence
proteins have very similar maturation times [6], and since we are interested
in the relative rather than the absolute times of protein expression.
For the CWT strain, we cannot compare the cea-cel delay-time from our
simulations with experimental results due to the lack of reporter plasmids
(see main text). To still be able to validate our stochastic simulations with
experimental data in this case, we use the time between the beginning of
the SOS response and cell lysis (referred to as “lysis time”), which we also
measured in experiments (see Fig. S8). The absolute values of the lysis time
will differ between our simulations and experiments, as the simulations do
not account for maturation times and other processes of equal duration in
all three strains. Therefore, we do not compare lysis times themselves, but
the differences of the CREP1 and CWT strain’s lysis times, which eliminates
these constant factors.
In the following, we discuss the results of our stochastic simulations for
the experiments presented in the main text.
4.1 The role of CsrA
As a first step to validate the mathematical model for the SREP1 strain (that
is, with no ssDNA in the system), we test the role of CsrA for the cea-cel
delay. The corresponding experiment varied the binding affinity of CsrA
to long mRNA, see Fig. 2E in the main text. Specifically, the experiment
measured the average cea-cel delay-time for the original SREP1 strain, and
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for two mutant strains (CsrA1 and CsrA2) with higher and lower CsrA
binding affinity, respectively. The results of these experiments (see Fig. 2E)
showed that an increased CsrA binding affinity leads to longer average cea-
cel delay-times, since the regulation of long mRNA by CsrA sequestration
happens more effectively with stronger CsrA binding. Consequently, we
found a much shorter average cea-cel delay for the mutant with lower
binding affinity. In our mathematical model defined by eqs. (18)-(21), the
binding affinity of CsrA for long mRNA relates to the parameter k+M, which
appears in the effective coupled degradation parameter, kM =
k+MδCMA
k−M+δCMA
(see Ref. [9] for details on this equation). However, the experiments do
not measure the rates k+M and k
−
M, but their ratio k
−
M/k
+
M, known as KD
value (see Fig. 2D of the main text). Since the degradation rate of the
complexes is much lower than the dissociation rate (this follows from the
fast complex equilibration assumption), we can determine kM from the
complex degradation and the KD values:
kM =
k+MδCMA
k−M + δCMA
≈ k
+
MδCMA
k−M
=
δCMA
KD
(22)
We used eq. (22) and KD values given in Fig. 2D to determine the binding
parameter constants kM for the SREP1 strain and its two mutants CsrA1
and CsrA2. Using these results, we then performed a set of numerical
simulations, and recorded the cea-cel delay-times. The mean delay times
for different values of kM are shown in main text Fig. 2F, where we also
give the parameter values. For the cea-cel delay-times we find the same
behaviour as in the experiments: higher values of kM result in broader
delay time distributions with a larger average delay time, whereas smaller
values give a narrow delay time distribution with an average delay close
to the start of the SOS signal. Our results show that the binding of CsrA
to long mRNA has a key influence on the delay time distribution. This
highlights the critical role of CsrA for the delay between toxin production
and release. Therefore, we expect regulative components affecting the
abundance of CsrA to have an indirect effect on the duration of the cea-cel
delay.
4.2 cea-cel delay in the five different strains
The experiments discussed in the main text show that the CREP1,CREP2, CWT,
SREP1 and SREP2 all have very different cea-cel delay times: The CREP1 strain,
for instance, lyses almost immediately after cea expression, whereas the
SREP1 strain shows a significant cea-cel delay. In this section, we employ
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stochastic simulations of the model described in eqs. (18)-(21) to study the
origin of this difference and the effects of ssDNA production. Moreover, we
infer the cea-cel delay in the CWT strain from this analysis, which cannot be
measured directly in experiments. To this end, we modelled the five strains
in our simulations by setting PCOL and PREP to the corresponding values
(see Table S5): PCOL = 20 and PREP = 0 for CWT, PCOL = 20 and PREP = 55
for CREP1, PCOL = 20 and PREP = 13 for CREP2, PCOL = 0 and PREP = 55
for the SREP1 strain, and PCOL = 0 and PREP = 13 for the SREP2 strain. For
each strain, we simulated 2000 realisations for different ssDNA production
rates (αD) to investigate the role of this novel regulatory component. The
results of these simulations are depicted in the form of cea-cel delay-time
histograms in Fig. S6, in which we, for a clear and concise discussion, only
depict the results for the CREP1, SREP1, and CWT strains.
As we showed in section 1, only two factors can in principle be re-
sponsible for the different cea-cel delays: The total plasmid copy number,
and the production of ssDNA. To separately study the influence of total
plasmid copy number in the strains, we first analyse the case of no ssDNA
production (αD = 0). The delay-time histograms of the three strains for this
case are depicted in the first column of Fig. S6. Comparing the histograms,
we find that the total plasmid copy number has a significant effect: The
cea-cel delay distribution of the CREP1 strain (75 plasmids in total) has a
shorter tail and a more pronounced peak at short lysis times compared
to the distribution of the SREP1 strain (55 plasmids in total), and the CWT
strain (with only 20 plasmids) shows almost no lysis at all. The average
delay-time of the SREP1 strain (68 minutes) is in good agreement with ex-
perimental values (see Fig. 2E). For the other strains, however, the results
do not match: The CREP1 strain has a mean delay time of 24.1minutes,
which is significantly larger than the value we find in our experiments.
Our experiments also find that the wild-type indeed does lyse after SOS
responses (see Fig. S8), while the histogram of CWT predicts no lysis. These
results for αD = 0 show that the plasmid copy number does not suffice to
explain the quantitative and (for the wild-type) qualitative behaviour found
in our experiments. However, it already accounts for significant differences
in the cea-cel delay-time distributions between the strains.
Before we study the additional effects of ssDNA, we discuss the origin
of these differences in the cea-cel delay-time distributions. To this end, we
consider the time evolution of the average levels of free CsrA and long
mRNA, which are depicted for αD = 0 in the first column of Fig. S7. We
find for all three strains that, after the initial equilibration, the average
number of CsrA molecules remains at a constant value before an SOS
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response (t < 200 min), which results from the interactions of CsrA with
all its binding partners. Before an SOS signal, the three strains exhibit
roughly the same average CsrA level. This changes after the response to
an SOS signal (200 min < t < 500 min), which reduces the average CsrA
level in all three strains: The CREP1 strain, containing 75 plasmids, has the
lowest CsrA levels, whereas the wild-type strain with only 20 plasmids has
a significantly higher level.
Comparing the CsrA and long mRNA levels with the corresponding cea-
cel delay-time distributions in Fig. S6 shows that the different cea-cel delay
time distributions are correlated with the average levels of free CsrA (and
free long mRNA): The lower the average CsrA level during a SOS signal,
the shorter the average cea-cel delay-time, and the narrower the delay-time
distribution. We can explain this correlation in our mathematical model by
the fact that long mRNA production increases in form of stochastic bursts
during SOS responses (see section 2). The long mRNAs produced during
these bursts must first sequester free CsrA, before their abundance is high
enough to produce lysis proteins from it. For the CWT strain, the CsrA level
during the SOS response is too high to be sequestered enough by stochastic
long mRNA bursts (see Fig. S7 and Fig. S6). For the SREP1 and the CREP1
strain, however, CsrA levels reach a sufficiently low average abundance
during an SOS response that stochastic bursts of free long mRNA are
possible, and eventually lysis protein is produced. The average level of free
CsrA therefore determines the probability and hence the timing of lysis.
In Fig. S7 we can also see that the single trajectories of CsrA abundance
differ qualitatively between the three strains: The trajectories of the CREP1
strain show large and abrupt deviations from the mean value, whereas the
abundance of CsrA is closer to the mean in the CWT strain. The reason
for this difference is the plasmid copy number in each strain: The more
plasmids with LexA-regulated promoters, the more CsrA-sequestering
elements are produced during an SOS response, and thus the more suscep-
tible the system will be to stochastic bursts in the SOS response, increasing
the probability of lysis. We already discussed in the previous paragraph
that the number of plasmids also strongly affects the average level of free
CsrA, as more plasmids cause a larger average number of promoters to
be unrepressed. This effect is due to the fact that the repressor of the
ColicinE2 operon, LexA, stochastically binds to and dissociates from the
promoter, and thus triggers long mRNA production for short times even
in the absence of an SOS signal. The more plasmids present, the larger
the number of (transiently) derepressed promoters, and hence the more
CsrA-sequestering long mRNA the cell contains. These relations explain
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the differences in the cea-cel delay between the three strains.
Finally, in order to characterise the additional effect of ssDNA, we
consider the plots with ssDNA production (that is, with αD > 0) in Fig. S6.
As the ssDNA production rate αD increases from 0, the average delay times
in the CREP1 and CWT strain decrease, and also several cells in the CWT strain
lyse (see the CWT histogram for αD = 1 in Fig. S6). We attribute this to the
fact that increasing αD results in lower average CsrA levels in the CREP1
and CWT strain, see Fig. S7. Consequently, the average cea-cel delay-times
in Fig. S6 decrease, and lysis of CWT bacteria becomes possible. The SREP1
strain, which contains no ssDNA-producing ColicinE2 plasmid, but only
reporter plasmids, is not affected by the increase of this parameter. The
experimentally observed difference in mean delay times of the CREP1 and
SREP1 strain occur when the ssDNA production rate reaches αD = 7 (see
Fig. S6). At this rate, also the CWT shows a broad cea-cel delay distribution.
For the CWT strain, we cannot compare the average cea-cel delay-time from
our simulations with experimental results, but have to use the lysis time.
For αD = 7, this difference is in the same order of magnitude as the
experimental results (see Fig. S8). If the ssDNA production rate becomes
too high, large fractions of the cell ensemble lyse even in the absence of an
SOS signal, which is not seen for the CREP1 strain in experiments.
Taken together, these results show that the additional sequestration
of CsrA by ssDNA is required for cell lysis in the CWT strain, and hence
necessary to produce the experimentally observed cea-cel delays. Therefore,
ssDNA plays a key role in the regulation of ColicinE2 release.
4.3 sRNA knock-out mutants
In the main text we also discuss experiments with different sRNA knock-
out mutant strains, see Fig. S4. While the two single knock-out cases
(no CsrB or no CsrC) are automatically accounted for by the effective
sRNA (see the bullet points on sRNA in section 2), the special case of the
double sRNA knock-out mutant corresponds to setting αS,0 ≡ αS,c ≡ 0
in eq. (19) of our model. This means that no sRNA would be produced,
which is the main CsrA-sequestering element in our mathematical model.
Therefore, our model predicts a large abundance of free CsrA for the
double sRNA knock-out case, and hence a significantly larger cea-cel delay.
However, we do not see this behaviour in our experiments (see Figs. S2
and S4), which in contrast show shorter average cea-cel delay-times in the
double knock-out mutant. These experimental results indicate that, in the
absence of the two sRNAs, yet unknown regulatory mechanisms become
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important. In the derivation of our mathematical model (see section 2),
we eliminated any subordinate targets for CsrA, and focussed on the
main CsrA-sequestering elements in E. coli, the sRNAs CsrB and CsrC [7].
Hence, adjusting our model for the double sRNA knock-out mutant would
first require to experimentally investigate the detailed interactions and
components of the yet unknown regulatory mechanisms, and then to
replace the S component and its interactions correspondingly in the model.
As the double knock-out mutant is not part of our investigation of the
cea-cel delay-time in the main text, we do not further extend our model for
this very special case. In all other strains and mutants discussed in the
main text and the Supplementary Information, sRNAs are produced and
also are the main CsrA regulator. Therefore, the aforementioned differences
between theoretical model and experimental observations that arise with
the double sRNA knock-out mutant do not affect any statements we derive
for the single knock-out or original strains using our model, eqs. (18)-(21).
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Fig. S3: Biochemical network involved in the post-transcriptional regulation
of ColicinE2. The top part shows the complete network, involving all
interactions and components considered in our manuscript. This complex
description of the network can be reduced to the set of effective interactions
shown the lower panel. The derivation of these effective descriptions is
given in section 2 of the theorz part of the Supplementary Information.
Fig. S6: cea-cel delay-time distributions and average cea-cel delay times for
different ssDNA production rates and strains. The SREP1 strain does not
produce ssDNA, and is plotted (in green) only for the purpose of direct
comparison with the CREP1 strain. If no ssDNA is produced (αD = 0), we
find that the CREP1 strain shows a broader cea-cel delay-time distribution,
compared to the cases with ssDNA production. The wild-type strain does
not lyse at all in response SOS signal for αD = 0. If we increase the ssDNA
production rate, we find the experimentally observed behaviour that the
CREP1 strain shows no cea-cel delays. In the wild type strain, a certain
threshold rate of ssDNA production is required to induce a significant
level of lysis, emphasising the importance of ssDNA for toxin releases.
A comparison of the lysis time (t¯lysis) differences between the CREP1 and
CWT strains in the model with the lysis time differences in experiments
motivates the value of ssDNA production, αD = 1.9. Ensemble size: 2000
realisations.
Fig. S7: Average of the time evolution of the CsrA and long mRNA
abundance for different ssDNA production rates and strains. Between
t=200 and t=500, the system is subject to an SOS signal. In all cases, the
SOS signal initiates a decrease in CsrA abundance from a previously stable
level. This level is determined by the production, binding, and degradation
rates of CsrA and its complex partners. As higher levels take longer and
are also less likely to decrease to zero, they also directly affect the duration
of the average cea-cel delay-time. The three plots for αD = 0 also show
a single trajectory of long mRNA and CsrA in light green and light red,
respectively. Ensemble size: 2000 realisations.
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